{
  "country": "USA",
  "nodes": [
    {
      "id": "FDA-CHUNK0-REQ-001",
      "type": "clause",
      "text": "Sponsors shall not represent investigational drugs as safe or effective in promotional contexts",
      "section": "drug promotion",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK0-REQ-002",
      "type": "clause",
      "text": "Sponsors shall not commercially distribute investigational drugs",
      "section": "drug distribution",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK0-REQ-003",
      "type": "clause",
      "text": "Sponsors shall not test market investigational drugs",
      "section": "drug marketing",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK0-REQ-004",
      "type": "clause",
      "text": "Scientific information and findings about the drug may be exchanged and disseminated",
      "section": "scientific communication",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK0-REQ-005",
      "type": "clause",
      "text": "Sponsors shall not unduly prolong investigations after sufficient data exists for marketing application",
      "section": "investigation duration",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK0-REQ-006",
      "type": "clause",
      "text": "IRBs can be disqualified for non-compliance with regulations",
      "section": "Compliance",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK1-REQ-001",
      "type": "clause",
      "text": "Sponsors must meet applicable requirements for charging in clinical trials",
      "section": "clinical trial charging",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK1-REQ-002",
      "type": "clause",
      "text": "Sponsors must justify the amount to be charged for investigational drugs",
      "section": "cost justification",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK1-REQ-003",
      "type": "clause",
      "text": "Sponsors must obtain prior written FDA authorization to charge for investigational drugs",
      "section": "charging authorization",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK1-REQ-004",
      "type": "clause",
      "text": "FDA may withdraw charging authorization if it interferes with drug development",
      "section": "authorization withdrawal",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK1-REQ-005",
      "type": "clause",
      "text": "Drug must show potential clinical benefit advantage over available products",
      "section": "clinical benefit",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK1-REQ-006",
      "type": "clause",
      "text": "IRB must document findings when approving alterations to informed consent requirements",
      "section": "IRB documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK2-REQ-001",
      "type": "clause",
      "text": "Clinical trial data must be essential for establishing drug effectiveness or safety for initial approval",
      "section": "clinical trial data",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK2-REQ-002",
      "type": "clause",
      "text": "Clinical trial data must support significant labeling changes for approved drugs",
      "section": "drug labeling",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK2-REQ-003",
      "type": "clause",
      "text": "Sponsors must demonstrate that trials cannot be conducted without charging due to extraordinary drug costs",
      "section": "trial costs",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK2-REQ-004",
      "type": "clause",
      "text": "Charging for clinical trials may continue for the full trial duration unless FDA specifies shorter period",
      "section": "trial charging",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK2-REQ-005",
      "type": "clause",
      "text": "Sponsors must ensure charging for expanded access does not interfere with drug marketing approval",
      "section": "expanded access",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK2-REQ-006",
      "type": "clause",
      "text": "Submit investigational new drug applications per Part 312",
      "section": "IND submissions",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK2-REQ-007",
      "type": "clause",
      "text": "Submit new drug applications according to Part 314 requirements",
      "section": "NDA submissions",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK3-REQ-001",
      "type": "clause",
      "text": "Show evidence of sufficient enrollment in ongoing clinical trials needed for marketing approval",
      "section": "clinical trials",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK3-REQ-002",
      "type": "clause",
      "text": "Demonstrate adequate progress in drug development for marketing approval",
      "section": "drug development",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK3-REQ-003",
      "type": "clause",
      "text": "Submit development milestones planned for the next year in the investigational plan",
      "section": "development planning",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK3-REQ-004",
      "type": "clause",
      "text": "Charging authorization is limited to the specified number of patients approved for treatment use",
      "section": "cost recovery",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK3-REQ-005",
      "type": "clause",
      "text": "Charging for expanded access is limited to 1 year unless FDA specifies shorter period",
      "section": "cost recovery",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK4-REQ-001",
      "type": "clause",
      "text": "Direct costs for charging must include drug acquisition costs from manufacturing sources",
      "section": "cost recovery",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK4-REQ-002",
      "type": "clause",
      "text": "Direct costs must include shipping and handling costs for the drug",
      "section": "cost recovery",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK4-REQ-003",
      "type": "clause",
      "text": "Indirect costs include facilities and equipment costs primarily used for commercial production",
      "section": "cost recovery",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK4-REQ-004",
      "type": "clause",
      "text": "Sponsors may recover costs for monitoring expanded access INDs",
      "section": "expanded access cost recovery",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK4-REQ-005",
      "type": "clause",
      "text": "Sponsors may recover costs for IND reporting requirements compliance",
      "section": "expanded access cost recovery",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK5-REQ-001",
      "type": "clause",
      "text": "Sponsors must provide documentation supporting cost recovery calculations",
      "section": "cost documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK5-REQ-002",
      "type": "clause",
      "text": "Cost calculations must be reviewed and approved by an independent certified public accountant",
      "section": "financial audit",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK5-REQ-003",
      "type": "clause",
      "text": "Waiver requests may be submitted in an IND or IND amendment",
      "section": "waiver process",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK5-REQ-004",
      "type": "clause",
      "text": "Emergency waiver requests may be made by telephone or rapid communication",
      "section": "emergency waivers",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK5-REQ-005",
      "type": "clause",
      "text": "Waiver requests must explain why compliance is unnecessary or impossible",
      "section": "waiver justification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK5-REQ-006",
      "type": "clause",
      "text": "FDA may grant waivers if noncompliance poses no significant risk to human subjects",
      "section": "waiver approval",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK6-REQ-001",
      "type": "clause",
      "text": "Sponsor must submit IND to FDA before conducting clinical investigation with investigational new drug",
      "section": "IND submission",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK6-REQ-002",
      "type": "clause",
      "text": "Clinical investigations cannot begin until IND is in effect",
      "section": "study initiation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK6-REQ-003",
      "type": "clause",
      "text": "Separate IND required for clinical investigations with informed consent exceptions",
      "section": "informed consent exceptions",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK6-REQ-004",
      "type": "clause",
      "text": "FDA must provide written determination within 30 days of receiving IND with informed consent exception",
      "section": "FDA review timeline",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK6-REQ-005",
      "type": "clause",
      "text": "Clinical investigations with informed consent exceptions require prior written FDA authorization",
      "section": "informed consent exceptions",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK6-REQ-006",
      "type": "clause",
      "text": "IND may be submitted for one or more phases of investigation",
      "section": "IND submission",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK7-REQ-001",
      "type": "clause",
      "text": "Phase 1 studies should obtain sufficient pharmacokinetic and pharmacological data to design Phase 2 studies",
      "section": "clinical study design",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK7-REQ-002",
      "type": "clause",
      "text": "Phase 1 studies should include 20-80 total subjects and patients",
      "section": "study population",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK7-REQ-003",
      "type": "clause",
      "text": "Phase 2 studies must evaluate drug effectiveness for specific indications in patients",
      "section": "clinical efficacy",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK7-REQ-004",
      "type": "clause",
      "text": "Phase 2 studies must determine common short-term side effects and risks",
      "section": "safety monitoring",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK7-REQ-005",
      "type": "clause",
      "text": "Phase 2 studies should involve no more than several hundred subjects",
      "section": "study population",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK7-REQ-006",
      "type": "clause",
      "text": "Phase 2 studies must be well-controlled and closely monitored",
      "section": "study controls",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK8-REQ-001",
      "type": "clause",
      "text": "Phase 3 studies must include several hundred to several thousand subjects",
      "section": "clinical trials",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK8-REQ-002",
      "type": "clause",
      "text": "FDA must assure safety and rights of subjects in all investigation phases",
      "section": "subject protection",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK8-REQ-003",
      "type": "clause",
      "text": "FDA must assess scientific quality of Phase 2 and 3 clinical investigations",
      "section": "study quality",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK8-REQ-004",
      "type": "clause",
      "text": "FDA must evaluate likelihood that Phase 2-3 studies will meet marketing approval standards",
      "section": "study evaluation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK8-REQ-005",
      "type": "clause",
      "text": "Preliminary evidence of drug effectiveness must be obtained before Phase 3 studies",
      "section": "drug effectiveness",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK8-REQ-006",
      "type": "clause",
      "text": "IND submissions must contain sufficient information to accomplish FDA review objectives",
      "section": "documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK8-REQ-007",
      "type": "clause",
      "text": "IRB must review and approve informed consent forms when DOD determines consent is required",
      "section": "informed consent",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK9-REQ-001",
      "type": "clause",
      "text": "Initial IND submission should focus on general investigational plan and human study protocols",
      "section": "IND submission content",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK9-REQ-002",
      "type": "clause",
      "text": "Protocol amendments should build logically on previous submissions",
      "section": "protocol amendments",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK9-REQ-003",
      "type": "clause",
      "text": "Annual IND reports should report status of ongoing studies",
      "section": "annual reporting",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK9-REQ-004",
      "type": "clause",
      "text": "Annual IND reports should update the investigational plan for coming year",
      "section": "annual reporting",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK9-REQ-005",
      "type": "clause",
      "text": "Sponsors should follow IND format specified in \u00a7 312.23",
      "section": "IND format",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK9-REQ-006",
      "type": "clause",
      "text": "Sponsor-investigators may refer to manufacturer's IND if authorized by manufacturer",
      "section": "IND references",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK10-REQ-001",
      "type": "clause",
      "text": "Submit FDA Form-1571 cover sheet with IND application",
      "section": "application submission",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK10-REQ-002",
      "type": "clause",
      "text": "Include sponsor name, address, phone number, date and investigational drug name on cover sheet",
      "section": "application documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK10-REQ-003",
      "type": "clause",
      "text": "Identify clinical investigation phases on IND cover sheet",
      "section": "application documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK10-REQ-004",
      "type": "clause",
      "text": "Commit to not begin clinical investigations until IND is in effect",
      "section": "clinical compliance",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK10-REQ-005",
      "type": "clause",
      "text": "Commit to IRB review and approval of all studies in clinical investigation",
      "section": "IRB oversight",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK10-REQ-006",
      "type": "clause",
      "text": "Report proposed research activity changes to IRB per part 56 requirements",
      "section": "IRB oversight",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK11-REQ-001",
      "type": "clause",
      "text": "Name and title of person monitoring clinical investigation conduct must be specified",
      "section": "personnel documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK11-REQ-002",
      "type": "clause",
      "text": "Name and title of person responsible for drug safety evaluation must be documented",
      "section": "safety oversight",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK11-REQ-003",
      "type": "clause",
      "text": "Document CRO name, address and transferred obligations for any outsourced clinical studies",
      "section": "outsourcing documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK11-REQ-004",
      "type": "clause",
      "text": "IND application must include sponsor's or authorized representative's signature",
      "section": "application signatures",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK11-REQ-005",
      "type": "clause",
      "text": "Non-US signers must have US agent countersign IND with name and address",
      "section": "international requirements",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-001",
      "type": "clause",
      "text": "Include introductory statement with drug name and all active ingredients",
      "section": "drug information",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-002",
      "type": "clause",
      "text": "Provide summary of previous human experience with the drug",
      "section": "clinical history",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-003",
      "type": "clause",
      "text": "Report any safety/effectiveness-related drug withdrawals from other countries",
      "section": "safety reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK12-REQ-004",
      "type": "clause",
      "text": "Describe overall drug investigation plan for the following year",
      "section": "investigation planning",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-005",
      "type": "clause",
      "text": "Specify the indication(s) to be studied in clinical trials",
      "section": "trial design",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-006",
      "type": "clause",
      "text": "State estimated number of patients for planned studies",
      "section": "trial design",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK13-REQ-001",
      "type": "clause",
      "text": "Investigator's brochure must include a description of the drug substance and formulation with structural formula",
      "section": "investigator brochure",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK13-REQ-002",
      "type": "clause",
      "text": "Investigator's brochure must summarize pharmacological and toxicological effects in animals and humans",
      "section": "investigator brochure",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK13-REQ-003",
      "type": "clause",
      "text": "Investigator's brochure must summarize pharmacokinetics and biological disposition in animals and humans",
      "section": "investigator brochure",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK13-REQ-004",
      "type": "clause",
      "text": "Investigator's brochure must include safety and effectiveness data from prior clinical studies",
      "section": "investigator brochure",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK13-REQ-005",
      "type": "clause",
      "text": "Investigator's brochure must describe anticipated risks, side effects and required monitoring procedures",
      "section": "investigator brochure",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK13-REQ-006",
      "type": "clause",
      "text": "A protocol must be submitted for each planned study",
      "section": "study protocols",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK14-REQ-001",
      "type": "clause",
      "text": "Phase 1 protocols should outline estimated number of patients to be involved",
      "section": "protocol content",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK14-REQ-002",
      "type": "clause",
      "text": "Phase 1 protocols should specify safety exclusion criteria",
      "section": "safety criteria",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK14-REQ-003",
      "type": "clause",
      "text": "Phase 1 protocols must detail critical safety monitoring of vital signs and blood chemistry",
      "section": "safety monitoring",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK14-REQ-004",
      "type": "clause",
      "text": "Phase 1 protocol modifications not affecting safety must be reported in annual report only",
      "section": "change reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK14-REQ-005",
      "type": "clause",
      "text": "Phase 2 and 3 protocols should describe all study aspects in detail",
      "section": "protocol content",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK14-REQ-006",
      "type": "clause",
      "text": "Phase 2 and 3 protocols should include contingency plans for potential deviations",
      "section": "protocol design",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK15-REQ-001",
      "type": "clause",
      "text": "Provide name and qualifications of each investigator and subinvestigator",
      "section": "personnel documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK15-REQ-002",
      "type": "clause",
      "text": "Document name and address of research facilities to be used",
      "section": "facility documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK15-REQ-003",
      "type": "clause",
      "text": "Document name and address of each reviewing Institutional Review Board",
      "section": "IRB documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK15-REQ-004",
      "type": "clause",
      "text": "Define patient selection and exclusion criteria",
      "section": "study design",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK15-REQ-005",
      "type": "clause",
      "text": "Describe methods to minimize bias among subjects, investigators and analysts",
      "section": "study design",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK16-REQ-001",
      "type": "clause",
      "text": "Submit sufficient information to identify drug substance and ensure quality, purity and strength",
      "section": "drug documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK16-REQ-002",
      "type": "clause",
      "text": "Initial Phase 1 submissions should focus on raw materials and new drug substance identification/control",
      "section": "Phase 1 documentation",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK16-REQ-003",
      "type": "clause",
      "text": "Final specifications for drug substance and product must be submitted by end of investigation",
      "section": "specifications",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK16-REQ-004",
      "type": "clause",
      "text": "Submit stability data demonstrating drug substance/product are within acceptable limits for study duration",
      "section": "stability testing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK16-REQ-005",
      "type": "clause",
      "text": "Stability data scope may be limited for short-term clinical investigations",
      "section": "stability testing",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK16-REQ-006",
      "type": "clause",
      "text": "IRB must require documentation of informed consent per \u00a7 50.27",
      "section": "consent documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK17-REQ-001",
      "type": "clause",
      "text": "Submit information amendments for chemistry, manufacturing and control processes when expanding clinical trials",
      "section": "manufacturing documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK17-REQ-002",
      "type": "clause",
      "text": "Provide description of drug substance including physical, chemical and biological characteristics",
      "section": "drug substance documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK17-REQ-003",
      "type": "clause",
      "text": "Include name and address of drug substance manufacturer",
      "section": "manufacturer information",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK17-REQ-004",
      "type": "clause",
      "text": "Document acceptable limits and analytical methods for drug substance identity, strength, quality and purity",
      "section": "quality control",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK17-REQ-005",
      "type": "clause",
      "text": "Provide stability information for drug substance during toxicological and clinical studies",
      "section": "stability documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK17-REQ-006",
      "type": "clause",
      "text": "List all components used in manufacturing the investigational drug product",
      "section": "product composition",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK17-REQ-007",
      "type": "clause",
      "text": "Informed consent must describe foreseeable risks and discomforts",
      "section": "informed consent",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK18-REQ-001",
      "type": "clause",
      "text": "Document quantitative composition of investigational drug product including expected variations",
      "section": "drug composition",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK18-REQ-002",
      "type": "clause",
      "text": "Provide name and address of drug product manufacturer",
      "section": "manufacturer information",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK18-REQ-003",
      "type": "clause",
      "text": "Include description of manufacturing and packaging procedures appropriate for the product",
      "section": "manufacturing process",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK18-REQ-004",
      "type": "clause",
      "text": "Document acceptable limits and analytical methods for drug identity, strength, quality and purity",
      "section": "quality control",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK18-REQ-005",
      "type": "clause",
      "text": "Provide information to demonstrate product stability during planned clinical studies",
      "section": "stability testing",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK18-REQ-006",
      "type": "clause",
      "text": "Include description of composition, manufacture and control of placebos used in controlled trials",
      "section": "placebo control",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK19-REQ-001",
      "type": "clause",
      "text": "Submit information about individuals who evaluated safety study results and their qualifications",
      "section": "personnel qualifications",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK19-REQ-002",
      "type": "clause",
      "text": "Provide location where investigations were conducted and records are available for inspection",
      "section": "record keeping",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK19-REQ-003",
      "type": "clause",
      "text": "Submit informational amendments with additional safety data as drug development proceeds",
      "section": "safety reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK19-REQ-004",
      "type": "clause",
      "text": "Include description of pharmacological effects and drug mechanism of action in animals",
      "section": "pharmacology documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK19-REQ-005",
      "type": "clause",
      "text": "Document drug absorption, distribution, metabolism and excretion information if known",
      "section": "drug disposition",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK19-REQ-006",
      "type": "clause",
      "text": "Provide integrated summary of toxicological effects in animals and in vitro",
      "section": "toxicology documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK19-REQ-007",
      "type": "clause",
      "text": "Include results of acute, subacute and chronic toxicity tests based on drug nature and investigation phase",
      "section": "toxicology testing",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK20-REQ-001",
      "type": "clause",
      "text": "Provide full tabulated data for each toxicology study supporting clinical investigation safety",
      "section": "toxicology data",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK20-REQ-002",
      "type": "clause",
      "text": "Include statement confirming GLP compliance for each nonclinical laboratory study",
      "section": "regulatory compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK20-REQ-003",
      "type": "clause",
      "text": "Provide explanation if nonclinical study does not comply with GLP regulations",
      "section": "regulatory compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK20-REQ-004",
      "type": "clause",
      "text": "Submit summary of all previous human experience with investigational drug",
      "section": "clinical history",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK20-REQ-005",
      "type": "clause",
      "text": "Include detailed information about previous investigations or marketing in US or other countries",
      "section": "clinical history",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK20-REQ-006",
      "type": "clause",
      "text": "Provide detailed information from controlled trials relevant to drug effectiveness",
      "section": "clinical evidence",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK20-REQ-007",
      "type": "clause",
      "text": "Physicians may provide emergency care as permitted by applicable laws",
      "section": "emergency care",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK21-REQ-001",
      "type": "clause",
      "text": "Provide full published material relevant to investigation safety and drug effectiveness assessment",
      "section": "documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK21-REQ-002",
      "type": "clause",
      "text": "Less directly relevant published material may be supplied via bibliography",
      "section": "documentation",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK21-REQ-003",
      "type": "clause",
      "text": "For combination drugs, provide safety/effectiveness information for each active component",
      "section": "combination drugs",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK21-REQ-004",
      "type": "clause",
      "text": "List countries where drug has been marketed outside US",
      "section": "international marketing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK21-REQ-005",
      "type": "clause",
      "text": "List countries where drug was withdrawn for safety/effectiveness reasons",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK21-REQ-006",
      "type": "clause",
      "text": "Submit information on drug dependence and abuse potential for psychotropic substances",
      "section": "drug safety",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK21-REQ-007",
      "type": "clause",
      "text": "Adequate provisions must exist to protect subject privacy and data confidentiality",
      "section": "privacy protection",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK2-REQ-008",
      "type": "clause",
      "text": "Submit bioavailability/bioequivalence data for human drugs per Part 320",
      "section": "BA/BE submissions",
      "clause_number": "REQ-008",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK3-REQ-006",
      "type": "clause",
      "text": "Sponsors may only recover direct costs specifically attributed to providing the authorized investigational drug",
      "section": "cost recovery",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK3-REQ-007",
      "type": "clause",
      "text": "Submit product development protocol for medical devices under section 515",
      "section": "device development",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK4-REQ-006",
      "type": "clause",
      "text": "Sponsors may recover administrative costs directly associated with expanded access INDs",
      "section": "expanded access cost recovery",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK11-REQ-006",
      "type": "clause",
      "text": "IND application must include a table of contents",
      "section": "application format",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK14-REQ-007",
      "type": "clause",
      "text": "All protocols must state study objectives and purpose",
      "section": "protocol content",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK15-REQ-006",
      "type": "clause",
      "text": "Document planned drug dosage, maximum dose and duration of patient exposure",
      "section": "drug administration",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK15-REQ-007",
      "type": "clause",
      "text": "Describe procedures and tests to monitor drug effects and minimize risk to subjects",
      "section": "safety monitoring",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK16-REQ-007",
      "type": "clause",
      "text": "IRB may waive written consent for minimal risk research",
      "section": "consent documentation",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK16-REQ-008",
      "type": "clause",
      "text": "IRB may grant exception from informed consent for emergency research under \u00a7 50.24",
      "section": "emergency research",
      "clause_number": "REQ-008",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK22-REQ-001",
      "type": "clause",
      "text": "Phase 1 studies of radioactive drugs must include data for dosimetry calculations",
      "section": "radioactive drug studies",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK22-REQ-002",
      "type": "clause",
      "text": "Radioactive drug applications must include radiation-absorbed dose calculations for whole body and critical organs",
      "section": "radioactive drug documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK22-REQ-003",
      "type": "clause",
      "text": "Applications must include plans for assessing pediatric safety and effectiveness",
      "section": "pediatric studies",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK22-REQ-004",
      "type": "clause",
      "text": "Sponsors must provide any additional information requested by FDA for application review",
      "section": "application documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK22-REQ-005",
      "type": "clause",
      "text": "References to previously submitted information must identify file name, reference number, volume and page number",
      "section": "documentation references",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK22-REQ-006",
      "type": "clause",
      "text": "References to third-party submissions must include signed authorization from the original submitter",
      "section": "documentation references",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK23-REQ-001",
      "type": "clause",
      "text": "Submit accurate and complete English translation of all non-English IND parts",
      "section": "document translation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK23-REQ-002",
      "type": "clause",
      "text": "Submit original literature publications for any translated documents",
      "section": "document submission",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK23-REQ-003",
      "type": "clause",
      "text": "Submit one original and two copies of all IND submissions, amendments and reports",
      "section": "document submission",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK23-REQ-004",
      "type": "clause",
      "text": "Amend IND as needed to ensure clinical investigations follow included protocols",
      "section": "protocol management",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK23-REQ-005",
      "type": "clause",
      "text": "Submit separate IND for clinical investigations with emergency research informed consent exceptions",
      "section": "emergency research",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK23-REQ-006",
      "type": "clause",
      "text": "IRB must document written procedures as required by \u00a7 56.108",
      "section": "procedures documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK23-REQ-007",
      "type": "clause",
      "text": "IRB must maintain statements of significant new findings provided to subjects",
      "section": "subject communications",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK24-REQ-001",
      "type": "clause",
      "text": "Initial IND submissions must be numbered 000",
      "section": "document numbering",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK24-REQ-002",
      "type": "clause",
      "text": "Subsequent IND submissions must be numbered chronologically with three-digit serial numbers",
      "section": "document numbering",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK24-REQ-003",
      "type": "clause",
      "text": "Sponsors must identify on cover sheet if investigation has informed consent exception under \u00a750.24",
      "section": "informed consent",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK24-REQ-004",
      "type": "clause",
      "text": "Sponsors must submit protocol amendments to FDA for any new study not in existing IND",
      "section": "protocol amendments",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK24-REQ-005",
      "type": "clause",
      "text": "New study protocols must be approved by the IRB before study begins",
      "section": "protocol approval",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK24-REQ-006",
      "type": "clause",
      "text": "Submit protocol amendments for safety-significant changes to Phase 1 protocols",
      "section": "protocol amendments",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK25-REQ-001",
      "type": "clause",
      "text": "Submit protocol amendment for any increase in drug dosage or duration of exposure beyond current protocol",
      "section": "protocol amendments",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK25-REQ-002",
      "type": "clause",
      "text": "Submit protocol amendment for any significant increase in number of study subjects",
      "section": "protocol amendments",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK25-REQ-003",
      "type": "clause",
      "text": "Submit protocol amendment for significant changes in study design like adding/dropping control groups",
      "section": "protocol amendments",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK25-REQ-004",
      "type": "clause",
      "text": "Submit protocol amendment when adding new safety monitoring procedures or dropping existing ones",
      "section": "safety monitoring",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK25-REQ-005",
      "type": "clause",
      "text": "Submit protocol changes to FDA for review before implementation",
      "section": "regulatory submission",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK25-REQ-006",
      "type": "clause",
      "text": "Obtain IRB approval for protocol changes before implementation",
      "section": "IRB approval",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK26-REQ-001",
      "type": "clause",
      "text": "Protocol amendments for immediate hazards must be subsequently notified to FDA",
      "section": "protocol amendments",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK26-REQ-002",
      "type": "clause",
      "text": "Protocol amendments for immediate hazards must be notified to reviewing IRB per \u00a756.104(c)",
      "section": "protocol amendments",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK26-REQ-003",
      "type": "clause",
      "text": "Sponsor must submit protocol amendment when adding new investigator to existing protocol",
      "section": "investigator management",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK26-REQ-004",
      "type": "clause",
      "text": "Sponsor must notify FDA within 30 days of adding new investigator",
      "section": "investigator management",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK26-REQ-005",
      "type": "clause",
      "text": "Protocol amendments must be clearly identified with specific amendment type in title",
      "section": "documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK26-REQ-006",
      "type": "clause",
      "text": "New protocol amendments must include copy of protocol and description of key differences",
      "section": "documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK27-REQ-001",
      "type": "clause",
      "text": "Submit protocol amendments before implementing any new protocol or protocol changes",
      "section": "protocol amendments",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK27-REQ-002",
      "type": "clause",
      "text": "Reference specific technical information in IND to support clinically significant protocol changes",
      "section": "protocol documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK27-REQ-003",
      "type": "clause",
      "text": "Identify location of referenced IND information by name, reference number, volume and page number",
      "section": "documentation references",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK27-REQ-004",
      "type": "clause",
      "text": "Submit new investigator additions and investigator information updates at 30-day intervals",
      "section": "investigator updates",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK27-REQ-005",
      "type": "clause",
      "text": "Group multiple protocol/change submissions into a single submission when feasible",
      "section": "submission process",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK27-REQ-006",
      "type": "clause",
      "text": "FDA may send disqualification notice to sponsors and investigators",
      "section": "notifications",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK27-REQ-007",
      "type": "clause",
      "text": "FDA may publish disqualification notice in Federal Register",
      "section": "public notification",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK28-REQ-001",
      "type": "clause",
      "text": "Sponsor shall report essential IND information via information amendment when not covered by other reports",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK28-REQ-002",
      "type": "clause",
      "text": "Information amendments must prominently identify their contents with clear headers",
      "section": "documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK28-REQ-003",
      "type": "clause",
      "text": "Information amendments must include a statement of nature and purpose",
      "section": "documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK28-REQ-004",
      "type": "clause",
      "text": "Information amendments must contain organized data in scientific review format",
      "section": "documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK28-REQ-005",
      "type": "clause",
      "text": "Information amendments should not be submitted more frequently than every 30 days",
      "section": "submission timing",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK10-REQ-007",
      "type": "clause",
      "text": "Submit all technical information supporting IND if not referencing scientific literature",
      "section": "technical documentation",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK12-REQ-007",
      "type": "clause",
      "text": "Document any anticipated severe or serious risks based on toxicology",
      "section": "safety assessment",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK13-REQ-007",
      "type": "clause",
      "text": "Phase 1 study protocols may be less detailed and more flexible than Phase 2/3 protocols",
      "section": "study protocols",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK14-REQ-008",
      "type": "clause",
      "text": "All protocols must include investigator qualifications and contact information",
      "section": "investigator information",
      "clause_number": "REQ-008",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK18-REQ-007",
      "type": "clause",
      "text": "Provide copies of all labels and labeling to be given to investigators",
      "section": "labeling",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK18-REQ-008",
      "type": "clause",
      "text": "Submit environmental analysis requirements or claim categorical exclusion",
      "section": "environmental analysis",
      "clause_number": "REQ-008",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK24-REQ-007",
      "type": "clause",
      "text": "Submit protocol amendments for significant changes to Phase 2 or 3 protocols",
      "section": "protocol amendments",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK26-REQ-007",
      "type": "clause",
      "text": "Protocol change amendments must describe changes and reference original submission",
      "section": "documentation",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK28-REQ-006",
      "type": "clause",
      "text": "Sponsors must report discontinuation of clinical investigations via information amendment",
      "section": "study discontinuation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK29-REQ-001",
      "type": "clause",
      "text": "Life-threatening adverse events must be reported if they place patient at immediate risk of death",
      "section": "adverse event reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK29-REQ-002",
      "type": "clause",
      "text": "Death must be reported as a serious adverse event outcome",
      "section": "adverse event reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK29-REQ-003",
      "type": "clause",
      "text": "Inpatient hospitalization or prolonged hospitalization must be reported as serious adverse events",
      "section": "adverse event reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK29-REQ-004",
      "type": "clause",
      "text": "Significant incapacity or disruption of normal life functions must be reported as serious adverse events",
      "section": "adverse event reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK29-REQ-005",
      "type": "clause",
      "text": "Congenital anomalies and birth defects must be reported as serious adverse events",
      "section": "adverse event reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK29-REQ-006",
      "type": "clause",
      "text": "Important medical events requiring intervention may be considered serious adverse events based on medical judgment",
      "section": "adverse event reporting",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK30-REQ-001",
      "type": "clause",
      "text": "Report any adverse event with reasonable possibility of being caused by the drug as a suspected adverse reaction",
      "section": "adverse event reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK30-REQ-002",
      "type": "clause",
      "text": "List all known adverse events in the investigator brochure at their observed specificity and severity",
      "section": "documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK30-REQ-003",
      "type": "clause",
      "text": "Document risk information in general investigational plan if no investigator brochure exists",
      "section": "documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK30-REQ-004",
      "type": "clause",
      "text": "Report adverse events of greater severity than those listed in documentation as unexpected",
      "section": "adverse event reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK30-REQ-005",
      "type": "clause",
      "text": "Classify adverse events with causal evidence as suspected adverse reactions",
      "section": "adverse event classification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK31-REQ-001",
      "type": "clause",
      "text": "Sponsors must promptly review all safety information from foreign and domestic sources",
      "section": "safety monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK31-REQ-002",
      "type": "clause",
      "text": "Sponsors must review safety data from clinical and epidemiological investigations",
      "section": "safety monitoring",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK31-REQ-003",
      "type": "clause",
      "text": "Sponsors must review safety data from animal and in vitro studies",
      "section": "safety monitoring",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK31-REQ-004",
      "type": "clause",
      "text": "Sponsors must review scientific literature and unpublished papers for safety information",
      "section": "safety monitoring",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK31-REQ-005",
      "type": "clause",
      "text": "Sponsors must notify FDA and investigators of potential serious risks within 15 calendar days",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK31-REQ-006",
      "type": "clause",
      "text": "Sponsors must review foreign regulatory authority reports for drugs not marketed in US",
      "section": "safety monitoring",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK32-REQ-001",
      "type": "clause",
      "text": "Sponsors must identify all previous IND safety reports submitted to FDA about similar suspected adverse reactions",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK32-REQ-002",
      "type": "clause",
      "text": "Sponsors must analyze significance of suspected adverse reactions compared to previous reports",
      "section": "safety analysis",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK32-REQ-003",
      "type": "clause",
      "text": "Sponsors must report any suspected adverse reaction that is both serious and unexpected",
      "section": "adverse event reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK32-REQ-004",
      "type": "clause",
      "text": "Report adverse events as suspected reactions only if evidence suggests causal relationship with the drug",
      "section": "adverse event classification",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK32-REQ-005",
      "type": "clause",
      "text": "Report single occurrences of uncommon events known to be strongly associated with drug exposure",
      "section": "adverse event reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK32-REQ-006",
      "type": "clause",
      "text": "Report events not commonly associated with drug exposure but uncommon in the exposed population",
      "section": "adverse event reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK33-REQ-001",
      "type": "clause",
      "text": "Sponsor must report findings from epidemiological studies that suggest significant human risk",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK33-REQ-002",
      "type": "clause",
      "text": "Sponsor must report findings from pooled analysis studies that suggest significant human risk",
      "section": "safety reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK33-REQ-003",
      "type": "clause",
      "text": "Significant safety findings must trigger updates to protocol and informed consent documents",
      "section": "safety documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK33-REQ-004",
      "type": "clause",
      "text": "Sponsor must report animal testing findings suggesting significant human risk",
      "section": "safety reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK33-REQ-005",
      "type": "clause",
      "text": "Sponsor must report in vitro testing findings suggesting significant human risk",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK33-REQ-006",
      "type": "clause",
      "text": "Report findings of mutagenicity, teratogenicity, carcinogenicity near human exposure levels",
      "section": "toxicity reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK34-REQ-001",
      "type": "clause",
      "text": "Sponsor must report any clinically important increase in serious suspected adverse reaction rates",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK34-REQ-002",
      "type": "clause",
      "text": "Submit IND safety reports in narrative format, FDA Form 3500A, or processable electronic format",
      "section": "report submission",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK34-REQ-003",
      "type": "clause",
      "text": "Foreign suspected adverse reactions may be submitted on CIOMS I Form instead of FDA Form 3500A",
      "section": "report submission",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK34-REQ-004",
      "type": "clause",
      "text": "Submit pooled analyses and overall findings from studies in narrative format",
      "section": "report submission",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK34-REQ-005",
      "type": "clause",
      "text": "Each FDA notification must be clearly marked as 'IND Safety Report'",
      "section": "report identification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK34-REQ-006",
      "type": "clause",
      "text": "Submit additional requested FDA data within 15 calendar days of request",
      "section": "data submission",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK35-REQ-001",
      "type": "clause",
      "text": "Report unexpected fatal or life-threatening adverse reactions to FDA within 7 calendar days of receipt",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK35-REQ-002",
      "type": "clause",
      "text": "Submit IND safety reports in FDA-specified format when required",
      "section": "safety reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK35-REQ-003",
      "type": "clause",
      "text": "Submit IND safety reports at FDA-specified frequency when required",
      "section": "safety reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK35-REQ-004",
      "type": "clause",
      "text": "Submit annual IND progress report within 60 days of IND anniversary date",
      "section": "progress reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK35-REQ-005",
      "type": "clause",
      "text": "Submit IND safety reports for adverse reactions in clinical studies of marketed US drugs",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK35-REQ-006",
      "type": "clause",
      "text": "Obtain FDA division director approval before changing safety report format or frequency",
      "section": "safety reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK36-REQ-001",
      "type": "clause",
      "text": "Study endpoints must be reported to FDA by sponsor as described in protocol",
      "section": "endpoint reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK36-REQ-002",
      "type": "clause",
      "text": "Serious unexpected adverse events with suspected drug causation must be reported even if part of study endpoint",
      "section": "adverse event reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK36-REQ-003",
      "type": "clause",
      "text": "Sponsor must promptly investigate all safety information received",
      "section": "safety monitoring",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK36-REQ-004",
      "type": "clause",
      "text": "Followup information to IND safety report must be submitted when available and marked as 'Followup'",
      "section": "safety reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK36-REQ-005",
      "type": "clause",
      "text": "Initially unreported adverse events later found reportable must be submitted within 15 calendar days of determination",
      "section": "adverse event reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK37-REQ-001",
      "type": "clause",
      "text": "Provide a brief summary of the status of each study in progress and completed during previous year",
      "section": "study reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK37-REQ-002",
      "type": "clause",
      "text": "Include study title, protocol number, purpose, patient population, and completion status in summary",
      "section": "study documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK37-REQ-003",
      "type": "clause",
      "text": "Report total planned subjects, current enrollment by age/gender/race, completions, and dropouts",
      "section": "enrollment reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK37-REQ-004",
      "type": "clause",
      "text": "Provide brief description of study results or interim results if available",
      "section": "results reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK37-REQ-005",
      "type": "clause",
      "text": "Sponsors may deny that submitted reports constitute admission of drug causing adverse events",
      "section": "adverse events",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK38-REQ-001",
      "type": "clause",
      "text": "Submit narrative or tabular summary of most frequent adverse experiences by body system",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK38-REQ-002",
      "type": "clause",
      "text": "Submit summary of all IND safety reports from the past year",
      "section": "safety reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK38-REQ-003",
      "type": "clause",
      "text": "Provide list of subjects who died during the investigation with cause of death",
      "section": "safety reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK38-REQ-004",
      "type": "clause",
      "text": "List subjects who dropped out due to adverse experiences",
      "section": "safety reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK38-REQ-005",
      "type": "clause",
      "text": "Submit description of findings related to drug actions, dose response and bioavailability",
      "section": "clinical findings",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK38-REQ-006",
      "type": "clause",
      "text": "List completed and in-progress preclinical studies with major findings",
      "section": "preclinical research",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK38-REQ-007",
      "type": "clause",
      "text": "Summarize significant manufacturing or microbiological changes from past year",
      "section": "manufacturing",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK39-REQ-001",
      "type": "clause",
      "text": "General investigational plan must contain information required under \u00a7 312.23(a)(3)(iv)",
      "section": "investigational plan",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK39-REQ-002",
      "type": "clause",
      "text": "Provide description of investigator brochure revisions and copy of new brochure when revised",
      "section": "documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK39-REQ-003",
      "type": "clause",
      "text": "Report significant Phase 1 protocol modifications made during previous year",
      "section": "protocol changes",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK39-REQ-004",
      "type": "clause",
      "text": "Summarize significant foreign marketing developments with drug during past year",
      "section": "marketing status",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK39-REQ-005",
      "type": "clause",
      "text": "Notify FDA when withdrawing an IND",
      "section": "IND withdrawal",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK39-REQ-006",
      "type": "clause",
      "text": "End all clinical investigations when IND is withdrawn",
      "section": "IND withdrawal",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK39-REQ-007",
      "type": "clause",
      "text": "Notify all investigators and IRBs if IND withdrawn for safety reasons",
      "section": "safety reporting",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK40-REQ-001",
      "type": "clause",
      "text": "Sponsor must submit an IND application to FDA before clinical investigation",
      "section": "IND submission",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK40-REQ-002",
      "type": "clause",
      "text": "Sponsor must comply with all requirements in parts 50 and 56 for clinical investigations",
      "section": "regulatory compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK40-REQ-003",
      "type": "clause",
      "text": "Investigators must conduct research in compliance with parts 50 and 56",
      "section": "investigator compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK40-REQ-004",
      "type": "clause",
      "text": "IND goes into effect 30 days after FDA receipt unless clinical hold is imposed",
      "section": "IND timing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK40-REQ-005",
      "type": "clause",
      "text": "FDA must notify sponsor in writing of IND receipt date",
      "section": "FDA notification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK40-REQ-006",
      "type": "clause",
      "text": "Sponsor may ship drug to named investigators 30 days after FDA receives IND",
      "section": "drug distribution",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK40-REQ-007",
      "type": "clause",
      "text": "Investigators must not administer drug until IND is in effect",
      "section": "drug administration",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK41-REQ-001",
      "type": "clause",
      "text": "FDA may communicate with sponsors about IND deficiencies or need for more data",
      "section": "regulatory communication",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK41-REQ-002",
      "type": "clause",
      "text": "FDA will provide advice on specific IND matters upon sponsor's request",
      "section": "regulatory guidance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK41-REQ-003",
      "type": "clause",
      "text": "FDA communications without clinical hold orders are advisory only and require no modifications",
      "section": "regulatory communication",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK41-REQ-004",
      "type": "clause",
      "text": "When a study is on clinical hold, no new subjects may receive the investigational drug",
      "section": "clinical holds",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK41-REQ-005",
      "type": "clause",
      "text": "Existing patients in a study placed on clinical hold must stop receiving investigational drug",
      "section": "clinical holds",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK42-REQ-001",
      "type": "clause",
      "text": "FDA may place clinical hold on Phase 1 studies if subjects face unreasonable risk of illness/injury",
      "section": "clinical hold criteria",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK42-REQ-002",
      "type": "clause",
      "text": "Clinical investigators named in IND must be qualified through scientific training and experience",
      "section": "investigator qualifications",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK42-REQ-003",
      "type": "clause",
      "text": "Investigator brochure must be accurate and complete without misleading information",
      "section": "documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK42-REQ-004",
      "type": "clause",
      "text": "IND must contain sufficient information to assess subject risks per \u00a7 312.23",
      "section": "risk assessment",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK42-REQ-005",
      "type": "clause",
      "text": "Studies for life-threatening conditions must not exclude participants based on reproductive risks alone",
      "section": "participant eligibility",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK43-REQ-001",
      "type": "clause",
      "text": "Women with reproductive potential must not include pregnant women in definition",
      "section": "participant definitions",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK43-REQ-002",
      "type": "clause",
      "text": "Life-threatening illnesses must be defined as conditions where death likelihood is high without intervention",
      "section": "medical definitions",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK43-REQ-003",
      "type": "clause",
      "text": "Gender-specific studies may be conducted under special circumstances",
      "section": "study design",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK43-REQ-004",
      "type": "clause",
      "text": "Single-gender studies must have concurrent or planned studies including the other gender",
      "section": "study design",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK43-REQ-005",
      "type": "clause",
      "text": "FDA may place Phase 2 or 3 studies on clinical hold if conditions in b(1)(i) through b(1)(v) apply",
      "section": "clinical holds",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK43-REQ-006",
      "type": "clause",
      "text": "FDA may place studies on hold if protocol is clearly deficient in meeting stated objectives",
      "section": "clinical holds",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK44-REQ-001",
      "type": "clause",
      "text": "FDA may place expanded access IND on hold if expanded access criteria in subpart I are not satisfied",
      "section": "clinical hold",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK44-REQ-002",
      "type": "clause",
      "text": "Expanded access protocols must comply with submission requirements in subpart I",
      "section": "protocol compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK44-REQ-003",
      "type": "clause",
      "text": "FDA may place ongoing expanded access IND on hold if criteria are no longer satisfied",
      "section": "clinical hold",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK44-REQ-004",
      "type": "clause",
      "text": "Non-adequate/well-controlled studies may be put on hold if interfering with adequate/well-controlled studies",
      "section": "study interference",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK44-REQ-005",
      "type": "clause",
      "text": "Non-adequate/well-controlled studies may be put on hold if impeding enrollment in other studies",
      "section": "enrollment interference",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK45-REQ-001",
      "type": "clause",
      "text": "Sufficient quantities of investigational drug must exist for both non-controlled and controlled investigations",
      "section": "drug supply",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK45-REQ-002",
      "type": "clause",
      "text": "FDA may halt studies if drug shows lack of effectiveness in well-controlled investigations",
      "section": "clinical hold criteria",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK45-REQ-003",
      "type": "clause",
      "text": "FDA may halt studies if another drug shows better benefit/risk for same indication and population",
      "section": "clinical hold criteria",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK45-REQ-004",
      "type": "clause",
      "text": "Sponsors must actively pursue marketing approval with due diligence",
      "section": "sponsor obligations",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK45-REQ-005",
      "type": "clause",
      "text": "Clinical holds for certain criteria should only apply to new enrollment, not existing participants",
      "section": "clinical hold scope",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK45-REQ-006",
      "type": "clause",
      "text": "FDA may place holds on investigations involving informed consent exceptions under \u00a750.24",
      "section": "informed consent",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK46-REQ-001",
      "type": "clause",
      "text": "FDA may place clinical holds if conditions in paragraphs (b)(1) or (b)(2) apply",
      "section": "clinical holds",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK46-REQ-002",
      "type": "clause",
      "text": "Criteria in \u00a7 50.24 must be satisfied and submitted for informed consent exceptions",
      "section": "informed consent",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK46-REQ-003",
      "type": "clause",
      "text": "Presidential waiver is required for investigations with informed consent exceptions under \u00a7 50.23(d)",
      "section": "informed consent waivers",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK46-REQ-004",
      "type": "clause",
      "text": "FDA must discuss deficiencies that may lead to clinical holds",
      "section": "deficiency management",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK46-REQ-005",
      "type": "clause",
      "text": "FDA must protect patients from immediate risks during clinical investigations",
      "section": "patient safety",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK47-REQ-001",
      "type": "clause",
      "text": "FDA must attempt to resolve issues with sponsor before issuing clinical hold order",
      "section": "clinical hold process",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK47-REQ-002",
      "type": "clause",
      "text": "Clinical hold orders must identify affected studies and explain the basis for action",
      "section": "clinical hold documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK47-REQ-003",
      "type": "clause",
      "text": "Division Director must provide written explanation within 30 days of clinical hold",
      "section": "clinical hold documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK47-REQ-004",
      "type": "clause",
      "text": "Investigations can only resume after FDA notification",
      "section": "clinical hold process",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK47-REQ-005",
      "type": "clause",
      "text": "Sponsor must correct deficiencies before clinical hold can be removed",
      "section": "clinical hold resolution",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK47-REQ-006",
      "type": "clause",
      "text": "Clinical hold orders may be issued by telephone or other rapid communication",
      "section": "clinical hold process",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK48-REQ-001",
      "type": "clause",
      "text": "FDA shall respond to clinical hold responses within 30 calendar days of receipt",
      "section": "clinical hold response",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK48-REQ-002",
      "type": "clause",
      "text": "Sponsors cannot proceed with clinical trials under hold until FDA notifies the hold is lifted",
      "section": "clinical hold compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK48-REQ-003",
      "type": "clause",
      "text": "Sponsors may request reconsideration of clinical hold decisions under \u00a7 312.48",
      "section": "clinical hold appeals",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK48-REQ-004",
      "type": "clause",
      "text": "FDA may place IND on inactive status if clinical hold exceeds 1 year",
      "section": "IND status",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK48-REQ-005",
      "type": "clause",
      "text": "Sponsors must end all clinical investigations if IND is terminated",
      "section": "IND termination",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK48-REQ-006",
      "type": "clause",
      "text": "Sponsors must recall or dispose of unused drug supplies upon IND termination",
      "section": "drug disposition",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK49-REQ-001",
      "type": "clause",
      "text": "FDA may terminate IND if human subjects would be exposed to unreasonable risk of illness or injury",
      "section": "subject safety",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK49-REQ-002",
      "type": "clause",
      "text": "IND must contain sufficient information to assess safety of clinical investigations",
      "section": "documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK49-REQ-003",
      "type": "clause",
      "text": "Manufacturing facilities and controls must maintain appropriate drug quality standards for subject safety",
      "section": "manufacturing controls",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK49-REQ-004",
      "type": "clause",
      "text": "Clinical investigations must be conducted as described in IND protocols",
      "section": "protocol compliance",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK49-REQ-005",
      "type": "clause",
      "text": "Drug must not be promoted or distributed for unauthorized commercial purposes",
      "section": "commercial restrictions",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK49-REQ-006",
      "type": "clause",
      "text": "IND submissions must not contain untrue statements or omit required material information",
      "section": "documentation accuracy",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK50-REQ-001",
      "type": "clause",
      "text": "Sponsors must submit accurate annual reports of investigations per \u00a7 312.33",
      "section": "reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK50-REQ-002",
      "type": "clause",
      "text": "Sponsors must report serious and unexpected adverse experiences per \u00a7 312.32",
      "section": "adverse event reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK50-REQ-003",
      "type": "clause",
      "text": "Sponsors must suspend investigations placed on clinical hold under \u00a7 312.42(b)(4)",
      "section": "clinical holds",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK50-REQ-004",
      "type": "clause",
      "text": "FDA may terminate INDs that remain inactive for 5 or more years",
      "section": "IND status",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK50-REQ-005",
      "type": "clause",
      "text": "Phase 2/3 investigational plans must be reasonable scientific plans to determine drug safety and efficacy",
      "section": "study design",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK50-REQ-006",
      "type": "clause",
      "text": "Sponsors have 30 days to respond to FDA IND termination proposals with corrections or explanations",
      "section": "IND termination process",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK51-REQ-001",
      "type": "clause",
      "text": "Sponsor may provide written explanation/correction or request conference with FDA upon notification",
      "section": "sponsor response",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK51-REQ-002",
      "type": "clause",
      "text": "IND shall be terminated if sponsor does not respond within allocated time",
      "section": "IND termination",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK51-REQ-003",
      "type": "clause",
      "text": "FDA must inform sponsor in writing if explanation/correction is not accepted",
      "section": "FDA communication",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK51-REQ-004",
      "type": "clause",
      "text": "Sponsor must request regulatory hearing within 10 days of receiving FDA's nonacceptance",
      "section": "regulatory hearing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK51-REQ-005",
      "type": "clause",
      "text": "FDA shall immediately terminate IND if investigation presents immediate danger to health",
      "section": "emergency termination",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK52-REQ-001",
      "type": "clause",
      "text": "FDA may terminate an IND if it poses an unreasonable risk to subjects",
      "section": "IND termination",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK52-REQ-002",
      "type": "clause",
      "text": "FDA shall notify sponsor in writing before placing IND on inactive status",
      "section": "IND status notification",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK52-REQ-003",
      "type": "clause",
      "text": "Sponsors have 30 days to respond to proposed inactive status notification",
      "section": "IND status response",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK52-REQ-004",
      "type": "clause",
      "text": "All investigators must be notified if IND is placed on inactive status",
      "section": "investigator notification",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK52-REQ-005",
      "type": "clause",
      "text": "Drug stocks must be returned or disposed of when IND becomes inactive",
      "section": "drug handling",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK52-REQ-006",
      "type": "clause",
      "text": "Annual reports are not required for INDs on inactive status",
      "section": "reporting",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK52-REQ-007",
      "type": "clause",
      "text": "FDA may place IND on inactive status after 2 years with no subject enrollment",
      "section": "IND status change",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK53-REQ-001",
      "type": "clause",
      "text": "Submit protocol amendment with investigational plan when resuming inactive IND",
      "section": "IND resumption",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK53-REQ-002",
      "type": "clause",
      "text": "Wait 30 days after FDA receives protocol amendment before resuming inactive IND investigations",
      "section": "IND resumption timeline",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK53-REQ-003",
      "type": "clause",
      "text": "Submit additional information supporting investigation via information amendment if needed",
      "section": "IND documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK53-REQ-004",
      "type": "clause",
      "text": "FDA may terminate IND that remains inactive for 5 or more years",
      "section": "IND termination",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK53-REQ-005",
      "type": "clause",
      "text": "Hold meetings between sponsor and FDA to resolve questions during clinical investigation",
      "section": "FDA communication",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK54-REQ-001",
      "type": "clause",
      "text": "Scientific/medical meetings shall be conducted and documented according to part 10",
      "section": "meeting documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK54-REQ-002",
      "type": "clause",
      "text": "Free, full and open communication should occur about scientific/medical questions during clinical investigation",
      "section": "communication",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK54-REQ-003",
      "type": "clause",
      "text": "End-of-Phase 2 meetings should be held to determine safety of proceeding to Phase 3",
      "section": "safety review",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK54-REQ-004",
      "type": "clause",
      "text": "End-of-Phase 2 meetings should evaluate Phase 3 plans and protocols",
      "section": "protocol review",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK54-REQ-005",
      "type": "clause",
      "text": "End-of-Phase 2 meetings should assess plans for pediatric safety and effectiveness",
      "section": "pediatric safety",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK54-REQ-006",
      "type": "clause",
      "text": "Pre-NDA meetings should be held before marketing application submission",
      "section": "application process",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK55-REQ-001",
      "type": "clause",
      "text": "Any IND sponsor may request and obtain an end-of-Phase 2 meeting",
      "section": "meeting eligibility",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK55-REQ-002",
      "type": "clause",
      "text": "End-of-Phase 2 meetings should occur before major Phase 3 commitments are made",
      "section": "meeting timing",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK55-REQ-003",
      "type": "clause",
      "text": "Sponsor should submit Phase 3 plan information at least 1 month before end-of-Phase 2 meeting",
      "section": "meeting preparation",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK55-REQ-004",
      "type": "clause",
      "text": "Submission must include summaries of Phase 1 and 2 investigations",
      "section": "documentation requirements",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK55-REQ-005",
      "type": "clause",
      "text": "Submission must include specific protocols for Phase 3 clinical studies",
      "section": "documentation requirements",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK55-REQ-006",
      "type": "clause",
      "text": "Submission must include plans for pediatric studies with timeline",
      "section": "pediatric requirements",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK56-REQ-001",
      "type": "clause",
      "text": "FDA must schedule meetings at times convenient for both FDA and sponsor",
      "section": "meeting scheduling",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK56-REQ-002",
      "type": "clause",
      "text": "Both sponsors and FDA may bring consultants to meetings",
      "section": "meeting attendance",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK56-REQ-003",
      "type": "clause",
      "text": "Meetings should focus on establishing agreement on overall Phase 3 plan and study design",
      "section": "meeting objectives",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK56-REQ-004",
      "type": "clause",
      "text": "FDA must provide judgment on required pediatric studies and deferral status",
      "section": "pediatric requirements",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK56-REQ-005",
      "type": "clause",
      "text": "FDA must record meeting agreements in minutes per \u00a710.65 and provide to sponsor",
      "section": "meeting documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK57-REQ-001",
      "type": "clause",
      "text": "Studies conducted per agreement shall be presumed sufficient for marketing approval",
      "section": "study design",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK57-REQ-002",
      "type": "clause",
      "text": "Sponsor should initiate pre-NDA/BLA meeting arrangements with FDA reviewing division",
      "section": "meetings",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK57-REQ-003",
      "type": "clause",
      "text": "Sponsor should submit meeting materials to FDA at least 1 month before pre-NDA/BLA meeting",
      "section": "documentation",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK57-REQ-004",
      "type": "clause",
      "text": "Pre-NDA/BLA meetings must identify studies relied on to establish drug effectiveness",
      "section": "effectiveness studies",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK57-REQ-005",
      "type": "clause",
      "text": "Pre-NDA/BLA meetings must identify status of pediatric safety and effectiveness studies",
      "section": "pediatric studies",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK58-REQ-001",
      "type": "clause",
      "text": "Application must include summary of clinical studies to be submitted",
      "section": "application content",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK58-REQ-002",
      "type": "clause",
      "text": "Application must propose format for organizing data submission",
      "section": "submission format",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK58-REQ-003",
      "type": "clause",
      "text": "Application must include status of pediatric studies",
      "section": "pediatric studies",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK58-REQ-004",
      "type": "clause",
      "text": "Sponsor should first attempt to resolve disputes with FDA division responsible for IND review",
      "section": "dispute resolution",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK58-REQ-005",
      "type": "clause",
      "text": "Unresolved disputes may be raised with designated FDA ombudsman",
      "section": "dispute resolution",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK58-REQ-006",
      "type": "clause",
      "text": "Ombudsman shall investigate disputes and facilitate timely resolution",
      "section": "dispute resolution",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK59-REQ-001",
      "type": "clause",
      "text": "Sponsors must select qualified investigators",
      "section": "investigator qualification",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK59-REQ-002",
      "type": "clause",
      "text": "Sponsors must provide investigators with information needed to conduct investigations properly",
      "section": "investigator support",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK59-REQ-003",
      "type": "clause",
      "text": "Sponsors must ensure proper monitoring of investigations",
      "section": "study monitoring",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK59-REQ-004",
      "type": "clause",
      "text": "Sponsors must ensure investigations follow the IND general plan and protocols",
      "section": "protocol compliance",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK59-REQ-005",
      "type": "clause",
      "text": "Sponsors must maintain an effective IND for the investigations",
      "section": "IND maintenance",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK59-REQ-006",
      "type": "clause",
      "text": "Sponsors must promptly inform FDA and investigators of significant new adverse effects or risks",
      "section": "safety reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK59-REQ-007",
      "type": "clause",
      "text": "Sponsors should discuss scientific/medical disputes directly with reviewing officials",
      "section": "dispute resolution",
      "clause_number": "REQ-007",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK60-REQ-001",
      "type": "clause",
      "text": "FDA must attempt to grant meeting requests involving important issues at mutually convenient times",
      "section": "meeting scheduling",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK60-REQ-002",
      "type": "clause",
      "text": "End-of-Phase 2 and pre-NDA meetings shall provide forum for resolving scientific/medical issues",
      "section": "regulatory meetings",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK60-REQ-003",
      "type": "clause",
      "text": "FDA may invite advisory committee members or consultants to dispute resolution meetings",
      "section": "dispute resolution",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK60-REQ-004",
      "type": "clause",
      "text": "Sponsors may bring their own consultants to meetings with FDA",
      "section": "meeting participation",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK60-REQ-005",
      "type": "clause",
      "text": "Transfer of sponsor obligations to CRO must be described in writing",
      "section": "obligation transfer",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK60-REQ-006",
      "type": "clause",
      "text": "Written transfer must specify which obligations are being assumed by the CRO",
      "section": "obligation transfer",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK61-REQ-001",
      "type": "clause",
      "text": "Contract research organizations must comply with all sponsor regulations they assume responsibility for",
      "section": "CRO compliance",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK61-REQ-002",
      "type": "clause",
      "text": "Sponsors must select investigators qualified by training and experience to investigate the drug",
      "section": "investigator qualification",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK61-REQ-003",
      "type": "clause",
      "text": "Sponsors shall only ship investigational drugs to participating investigators",
      "section": "drug control",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK61-REQ-004",
      "type": "clause",
      "text": "Sponsors must obtain signed FDA-1572 forms from investigators before they begin participation",
      "section": "investigator documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK61-REQ-005",
      "type": "clause",
      "text": "FDA-1572 forms must include investigator name and address",
      "section": "investigator documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK61-REQ-006",
      "type": "clause",
      "text": "FDA-1572 forms must include protocol names and code numbers for studies to be conducted",
      "section": "investigator documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK62-REQ-001",
      "type": "clause",
      "text": "Provide name and address of medical schools, hospitals, or research facilities conducting clinical investigations",
      "section": "facility documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK62-REQ-002",
      "type": "clause",
      "text": "Provide name and address of clinical laboratory facilities used in the study",
      "section": "facility documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK62-REQ-003",
      "type": "clause",
      "text": "Provide name and address of IRB responsible for study review and approval",
      "section": "IRB documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK62-REQ-004",
      "type": "clause",
      "text": "Investigator must conduct studies according to current protocols and notify sponsor of any changes",
      "section": "protocol compliance",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK62-REQ-005",
      "type": "clause",
      "text": "Investigator must personally conduct or supervise the investigations",
      "section": "study oversight",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK62-REQ-006",
      "type": "clause",
      "text": "Inform subjects that drugs are investigational and obtain proper informed consent",
      "section": "informed consent",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK62-REQ-007",
      "type": "clause",
      "text": "Report adverse experiences to sponsor per \u00a7 312.64",
      "section": "adverse event reporting",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK62-REQ-008",
      "type": "clause",
      "text": "Ensure all staff assisting in study conduct understand investigator brochure including risks",
      "section": "staff training",
      "clause_number": "REQ-008",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK63-REQ-001",
      "type": "clause",
      "text": "An IRB compliant with part 56 must review and approve the clinical investigation",
      "section": "IRB oversight",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK63-REQ-002",
      "type": "clause",
      "text": "Investigators must promptly report all unanticipated problems involving risks to human subjects to the IRB",
      "section": "safety reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK63-REQ-003",
      "type": "clause",
      "text": "Investigators must obtain IRB approval before making changes to the research",
      "section": "protocol changes",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK63-REQ-004",
      "type": "clause",
      "text": "Changes may be made without IRB approval only to eliminate immediate hazards to subjects",
      "section": "emergency changes",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK63-REQ-005",
      "type": "clause",
      "text": "Investigators must provide a list of all subinvestigators who will assist in the investigation",
      "section": "personnel documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK63-REQ-006",
      "type": "clause",
      "text": "Investigators must provide curriculum vitae or statement of qualifications",
      "section": "personnel documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK64-REQ-001",
      "type": "clause",
      "text": "Investigator must provide documentation of education, training and experience qualifying them as drug trial expert",
      "section": "investigator qualifications",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK64-REQ-002",
      "type": "clause",
      "text": "Phase 1 investigations must include planned duration and maximum number of subjects",
      "section": "protocol documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK64-REQ-003",
      "type": "clause",
      "text": "Phase 2/3 protocols must specify subject numbers, characteristics, clinical observations and laboratory tests",
      "section": "protocol documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK64-REQ-004",
      "type": "clause",
      "text": "Investigators must provide financial disclosure information for certification statements",
      "section": "financial disclosure",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK64-REQ-005",
      "type": "clause",
      "text": "Investigators must update financial information for 1 year after study completion",
      "section": "financial disclosure",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK64-REQ-006",
      "type": "clause",
      "text": "Sponsor shall select monitors qualified by training and experience",
      "section": "monitor selection",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK65-REQ-001",
      "type": "clause",
      "text": "Sponsor shall monitor progress of all investigations involving exception from informed consent",
      "section": "investigation monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK65-REQ-002",
      "type": "clause",
      "text": "Sponsor must submit copies of public disclosures to IND file and FDA Docket when received from IRB",
      "section": "documentation submission",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK65-REQ-003",
      "type": "clause",
      "text": "Sponsor shall monitor for IRB determinations of non-approval based on informed consent exceptions",
      "section": "IRB monitoring",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK65-REQ-004",
      "type": "clause",
      "text": "Sponsor must notify FDA in writing when IRB cannot approve research due to ethical concerns",
      "section": "regulatory notification",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK65-REQ-005",
      "type": "clause",
      "text": "Sponsor must notify other investigators and IRBs about research that cannot be approved",
      "section": "investigator notification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK65-REQ-006",
      "type": "clause",
      "text": "Sponsor must provide investigator brochure to each participating clinical investigator before study start",
      "section": "investigator documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK66-REQ-001",
      "type": "clause",
      "text": "Sponsor shall monitor the progress of all clinical investigations under their IND",
      "section": "investigation monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK66-REQ-002",
      "type": "clause",
      "text": "Sponsor must inform investigators of new drug observations, particularly adverse effects and safe use",
      "section": "safety communications",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK66-REQ-003",
      "type": "clause",
      "text": "Important safety information must be relayed to investigators per \u00a7 312.32",
      "section": "safety reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK66-REQ-004",
      "type": "clause",
      "text": "Sponsor shall secure compliance or discontinue drug shipments if investigator violates requirements",
      "section": "compliance enforcement",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK66-REQ-005",
      "type": "clause",
      "text": "When ending investigator participation, sponsor shall require return or disposal of investigational drug",
      "section": "drug accountability",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK66-REQ-006",
      "type": "clause",
      "text": "Safety information may be distributed via investigator brochures, reprints, reports, letters or other means",
      "section": "safety communications",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK67-REQ-001",
      "type": "clause",
      "text": "Sponsor shall review and evaluate drug safety and effectiveness evidence from investigators",
      "section": "safety monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK67-REQ-002",
      "type": "clause",
      "text": "Sponsor must submit safety reports to FDA as required under \u00a7 312.32",
      "section": "regulatory reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK67-REQ-003",
      "type": "clause",
      "text": "Sponsor shall submit annual investigation progress reports per \u00a7 312.33",
      "section": "regulatory reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK67-REQ-004",
      "type": "clause",
      "text": "Sponsor must discontinue investigations within 5 days if drug presents unreasonable risk",
      "section": "safety monitoring",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK67-REQ-005",
      "type": "clause",
      "text": "Sponsor shall notify FDA, IRBs and investigators of investigation discontinuance",
      "section": "safety notification",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK67-REQ-006",
      "type": "clause",
      "text": "Sponsor shall maintain records of investigational drug receipt, shipment and disposition",
      "section": "drug accountability",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK68-REQ-001",
      "type": "clause",
      "text": "Sponsor must maintain records of drug shipments including recipient, date, quantity and batch marks",
      "section": "record keeping",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK68-REQ-002",
      "type": "clause",
      "text": "Sponsor must maintain complete records of financial interests paid to clinical investigators",
      "section": "financial records",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK68-REQ-003",
      "type": "clause",
      "text": "Records must be retained for 2 years after marketing application approval",
      "section": "record retention",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK68-REQ-004",
      "type": "clause",
      "text": "If application not approved, records must be kept 2 years after discontinuing investigational use",
      "section": "record retention",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK68-REQ-005",
      "type": "clause",
      "text": "Sponsor must ensure return of unused investigational drug from investigators who discontinue participation",
      "section": "drug supply management",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK69-REQ-001",
      "type": "clause",
      "text": "Sponsor must maintain written records of investigational drug disposition",
      "section": "record keeping",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK69-REQ-002",
      "type": "clause",
      "text": "Investigator must conduct investigation according to signed statement, plan and regulations",
      "section": "protocol compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK69-REQ-003",
      "type": "clause",
      "text": "Investigator must protect rights, safety and welfare of subjects under their care",
      "section": "subject protection",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK69-REQ-004",
      "type": "clause",
      "text": "Investigator must control investigational drugs",
      "section": "drug control",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK69-REQ-005",
      "type": "clause",
      "text": "Investigator must obtain informed consent from each subject receiving the drug",
      "section": "informed consent",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK69-REQ-006",
      "type": "clause",
      "text": "Sponsor must retain reserve samples of test articles used in bioequivalence/bioavailability studies",
      "section": "sample retention",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK69-REQ-007",
      "type": "clause",
      "text": "Sponsor must release reserve samples to FDA upon request",
      "section": "FDA inspections",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK70-REQ-001",
      "type": "clause",
      "text": "Sponsor must allow FDA officers to access and verify clinical investigation records and reports",
      "section": "regulatory inspection",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK70-REQ-002",
      "type": "clause",
      "text": "Sponsor must submit records/reports to FDA upon written request",
      "section": "records submission",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK70-REQ-003",
      "type": "clause",
      "text": "Sponsor must stop drug shipments to investigators who fail to maintain/provide required records",
      "section": "compliance enforcement",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK70-REQ-004",
      "type": "clause",
      "text": "Controlled substance records must be made available to DEA for inspection upon request",
      "section": "controlled substances",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK70-REQ-005",
      "type": "clause",
      "text": "Controlled substances must be stored in securely locked, substantially constructed cabinet/enclosure",
      "section": "controlled substances storage",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK70-REQ-006",
      "type": "clause",
      "text": "Access to controlled substance storage must be limited to prevent theft/diversion",
      "section": "controlled substances security",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK71-REQ-001",
      "type": "clause",
      "text": "Investigator shall administer drug only to subjects under their personal supervision or subinvestigator supervision",
      "section": "drug administration",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK71-REQ-002",
      "type": "clause",
      "text": "Investigator shall not supply investigational drug to unauthorized persons",
      "section": "drug control",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK71-REQ-003",
      "type": "clause",
      "text": "Investigator must maintain records of drug disposition including dates, quantity and subject use",
      "section": "recordkeeping",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK71-REQ-004",
      "type": "clause",
      "text": "Investigator must return unused drug supplies to sponsor when study ends",
      "section": "drug disposition",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK71-REQ-005",
      "type": "clause",
      "text": "Investigator must maintain accurate case histories for each subject receiving investigational drug",
      "section": "documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK71-REQ-006",
      "type": "clause",
      "text": "Case histories must include signed and dated consent forms",
      "section": "informed consent",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK72-REQ-001",
      "type": "clause",
      "text": "Case history must document that informed consent was obtained prior to study participation",
      "section": "informed consent",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK72-REQ-002",
      "type": "clause",
      "text": "Investigators shall retain records for 2 years after marketing application approval",
      "section": "record retention",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK72-REQ-003",
      "type": "clause",
      "text": "Investigators shall furnish all reports to the drug sponsor",
      "section": "reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK72-REQ-004",
      "type": "clause",
      "text": "Investigators must immediately report any serious adverse events to the sponsor",
      "section": "safety reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK72-REQ-005",
      "type": "clause",
      "text": "Adverse event reports must include assessment of possible drug causation",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK72-REQ-006",
      "type": "clause",
      "text": "Serious adverse events that are study endpoints must be reported per protocol",
      "section": "safety reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK73-REQ-001",
      "type": "clause",
      "text": "Investigator must immediately report death from anaphylaxis events to the sponsor",
      "section": "adverse event reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK73-REQ-002",
      "type": "clause",
      "text": "Investigator must record and report nonserious adverse events according to protocol timeline",
      "section": "adverse event reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK73-REQ-003",
      "type": "clause",
      "text": "Investigator shall provide final report to sponsor after completing investigation participation",
      "section": "study reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK73-REQ-004",
      "type": "clause",
      "text": "Investigator shall provide accurate financial information to sponsor for certification/disclosure",
      "section": "financial disclosure",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK73-REQ-005",
      "type": "clause",
      "text": "Investigator shall update financial information for changes during study and 1 year after completion",
      "section": "financial disclosure",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK73-REQ-006",
      "type": "clause",
      "text": "Investigator shall ensure IRB review and approval of proposed clinical study",
      "section": "IRB oversight",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK74-REQ-001",
      "type": "clause",
      "text": "Investigators must report all unanticipated problems involving risk to human subjects to the IRB promptly",
      "section": "safety reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK74-REQ-002",
      "type": "clause",
      "text": "Investigators must obtain IRB approval before making changes to research protocols",
      "section": "protocol changes",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK74-REQ-003",
      "type": "clause",
      "text": "Investigators shall provide FDA officials access to inspect and copy research records upon request",
      "section": "regulatory inspection",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK74-REQ-004",
      "type": "clause",
      "text": "Subject names must remain confidential unless detailed case review is required",
      "section": "data privacy",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK74-REQ-005",
      "type": "clause",
      "text": "Controlled substances must be stored in a securely locked, substantially constructed cabinet",
      "section": "drug storage",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK74-REQ-006",
      "type": "clause",
      "text": "Access to controlled substance storage must be limited to prevent theft or diversion",
      "section": "drug security",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK75-REQ-001",
      "type": "clause",
      "text": "FDA must provide written notice to investigators who repeatedly or deliberately fail to comply with regulations",
      "section": "investigator notification",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK75-REQ-002",
      "type": "clause",
      "text": "FDA must offer non-compliant investigators opportunity to explain in writing or informal conference",
      "section": "investigator response",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK75-REQ-003",
      "type": "clause",
      "text": "Centers must discontinue disqualification if investigator explanation is accepted",
      "section": "disqualification process",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK75-REQ-004",
      "type": "clause",
      "text": "FDA must provide regulatory hearing opportunity if explanation not accepted",
      "section": "regulatory hearing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK75-REQ-005",
      "type": "clause",
      "text": "Commissioner must evaluate all information before determining investigator disqualification",
      "section": "disqualification decision",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK75-REQ-006",
      "type": "clause",
      "text": "Investigators must not submit false information in required reports",
      "section": "reporting integrity",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK76-REQ-001",
      "type": "clause",
      "text": "Commissioner must notify investigator when they are ineligible to receive test articles",
      "section": "investigator disqualification",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK76-REQ-002",
      "type": "clause",
      "text": "Commissioner must notify sponsors when their investigator is ineligible",
      "section": "investigator disqualification",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK76-REQ-003",
      "type": "clause",
      "text": "Commissioner must notify IRBs when an investigator is ineligible",
      "section": "investigator disqualification",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK76-REQ-004",
      "type": "clause",
      "text": "Procedures must expedite development of therapies for life-threatening illnesses",
      "section": "expedited review",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK76-REQ-005",
      "type": "clause",
      "text": "Procedures must expedite development of therapies for severely-debilitating illnesses",
      "section": "expedited review",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK76-REQ-006",
      "type": "clause",
      "text": "FDA may apply flexibility in safety and effectiveness standards based on drug types and uses",
      "section": "regulatory standards",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK77-REQ-001",
      "type": "clause",
      "text": "FDA must notify investigators of ineligibility determination and explain the basis",
      "section": "investigator notification",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK77-REQ-002",
      "type": "clause",
      "text": "Ineligible investigators cannot conduct clinical investigations supporting FDA applications",
      "section": "investigator eligibility",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK77-REQ-003",
      "type": "clause",
      "text": "FDA must examine applications containing data from ineligible investigators for unreliable data",
      "section": "data validation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK77-REQ-004",
      "type": "clause",
      "text": "FDA must notify sponsor if remaining data is inadequate after removing unreliable data",
      "section": "sponsor notification",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK77-REQ-005",
      "type": "clause",
      "text": "Sponsors shall have opportunity for regulatory hearing under part 16",
      "section": "regulatory hearings",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK78-REQ-001",
      "type": "clause",
      "text": "Commissioner shall terminate IND immediately upon finding unreliable data",
      "section": "regulatory enforcement",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK78-REQ-002",
      "type": "clause",
      "text": "Commissioner must notify sponsor and IRBs of IND termination",
      "section": "notifications",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK78-REQ-003",
      "type": "clause",
      "text": "Sponsor shall have opportunity for regulatory hearing before FDA on IND reinstatement",
      "section": "appeals process",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK78-REQ-004",
      "type": "clause",
      "text": "Sponsor must submit investigation results to FDA even if data deemed unreliable",
      "section": "data submission",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK78-REQ-005",
      "type": "clause",
      "text": "Commissioner shall withdraw product approval if it cannot be justified after removing unreliable data",
      "section": "product approval",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK78-REQ-006",
      "type": "clause",
      "text": "Ineligible investigator may be reinstated upon providing adequate compliance assurances",
      "section": "investigator eligibility",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK79-REQ-001",
      "type": "clause",
      "text": "FDA shall apply flexible standards while maintaining safety and effectiveness guarantees",
      "section": "regulatory standards",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK79-REQ-002",
      "type": "clause",
      "text": "Drug benefits must be evaluated relative to disease severity",
      "section": "drug evaluation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK79-REQ-003",
      "type": "clause",
      "text": "These procedures apply to drugs studied for life-threatening or severely-debilitating diseases",
      "section": "scope",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK79-REQ-004",
      "type": "clause",
      "text": "Sponsors may request early meetings with FDA to review preclinical and clinical study design",
      "section": "consultation",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK79-REQ-005",
      "type": "clause",
      "text": "FDA may invite outside experts to early consultation meetings when appropriate",
      "section": "consultation",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK80-REQ-001",
      "type": "clause",
      "text": "FDA reviewing officials shall honor requests for meetings with scientific consultants when resources permit",
      "section": "meetings",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK80-REQ-002",
      "type": "clause",
      "text": "Sponsors may consult FDA on applicability of procedures to specific products",
      "section": "consultation",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK80-REQ-003",
      "type": "clause",
      "text": "Sponsors may request pre-IND meetings with FDA before initial IND submission",
      "section": "pre-IND meetings",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK80-REQ-004",
      "type": "clause",
      "text": "Pre-IND meetings shall review and agree on animal studies design needed for human testing",
      "section": "pre-IND meetings",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK80-REQ-005",
      "type": "clause",
      "text": "Sponsors may request end-of-phase-1 meetings when phase 1 clinical data is available",
      "section": "phase 1 meetings",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK81-REQ-001",
      "type": "clause",
      "text": "Reach agreement on design of phase 2 controlled clinical trials for safety and effectiveness data",
      "section": "clinical trial design",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK81-REQ-002",
      "type": "clause",
      "text": "Discuss design and timing of pediatric patient studies",
      "section": "pediatric studies",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK81-REQ-003",
      "type": "clause",
      "text": "FDA may request submission of treatment protocol after promising phase 2 results",
      "section": "treatment protocols",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK81-REQ-004",
      "type": "clause",
      "text": "Treatment protocols must be reviewed under procedures in \u00a7\u00a7 312.305 and 312.320",
      "section": "protocol review",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK81-REQ-005",
      "type": "clause",
      "text": "Treatment protocol remains active while marketing application data is assembled and reviewed",
      "section": "protocol status",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK81-REQ-006",
      "type": "clause",
      "text": "Clinical hold may be placed on ongoing protocols per \u00a7 312.42(b)(3)(ii)",
      "section": "clinical holds",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK82-REQ-001",
      "type": "clause",
      "text": "FDA shall document agreements reached during end-of-phase 1 meetings using procedures from \u00a7 312.47(b)(1)",
      "section": "meeting documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK82-REQ-002",
      "type": "clause",
      "text": "FDA shall evaluate medical risk-benefit judgment for final marketing approval decisions",
      "section": "approval criteria",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK82-REQ-003",
      "type": "clause",
      "text": "FDA shall consider if drug benefits outweigh known and potential risks",
      "section": "risk assessment",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK82-REQ-004",
      "type": "clause",
      "text": "FDA shall consider disease severity and alternative therapy availability in approval decisions",
      "section": "approval criteria",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK82-REQ-005",
      "type": "clause",
      "text": "FDA shall seek advice from outside expert consultants or advisory committees for end-of-phase 1 marketing approvals",
      "section": "expert consultation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK82-REQ-006",
      "type": "clause",
      "text": "FDA must notify relevant advisory committee members when marketing applications are filed and available for review",
      "section": "committee notification",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK83-REQ-001",
      "type": "clause",
      "text": "FDA must describe in the response letter why research design results were insufficient for marketing approval",
      "section": "application review",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK83-REQ-002",
      "type": "clause",
      "text": "FDA must include advisory committee recommendations in the response letter",
      "section": "application review",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK83-REQ-003",
      "type": "clause",
      "text": "Marketing applications must comply with requirements in part 314 or part 600",
      "section": "application compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK83-REQ-004",
      "type": "clause",
      "text": "FDA may request sponsor agreement for postmarketing Phase 4 studies upon approval",
      "section": "postmarketing studies",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK83-REQ-005",
      "type": "clause",
      "text": "Phase 4 studies may include different doses, schedules, populations or longer duration than Phase 2",
      "section": "postmarketing studies",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK83-REQ-006",
      "type": "clause",
      "text": "FDA may conduct focused regulatory research on critical rate-limiting aspects",
      "section": "regulatory research",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK84-REQ-001",
      "type": "clause",
      "text": "FDA must monitor progress of clinical trials and facilitate their appropriate progress",
      "section": "trial monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK84-REQ-002",
      "type": "clause",
      "text": "Informed consent must be obtained from trial participants per Part 50",
      "section": "informed consent",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK84-REQ-003",
      "type": "clause",
      "text": "Institutional review board approval is required per Part 56",
      "section": "IRB approval",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK84-REQ-004",
      "type": "clause",
      "text": "Animal studies must be reviewed before initial human testing",
      "section": "preclinical testing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK84-REQ-005",
      "type": "clause",
      "text": "IND safety reports must be submitted to monitor adverse drug experiences",
      "section": "safety reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK84-REQ-006",
      "type": "clause",
      "text": "Safety update reports must be submitted during marketing application review",
      "section": "safety reporting",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK84-REQ-007",
      "type": "clause",
      "text": "Post-marketing adverse reaction reports must be submitted",
      "section": "safety reporting",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK85-REQ-001",
      "type": "clause",
      "text": "Imported investigational drugs must be subject to an active IND under \u00a7 312.40",
      "section": "drug imports",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK85-REQ-002",
      "type": "clause",
      "text": "US consignee for imported drugs must be the IND sponsor",
      "section": "drug imports",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK85-REQ-003",
      "type": "clause",
      "text": "US consignee may be a qualified investigator named in the IND",
      "section": "drug imports",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK85-REQ-004",
      "type": "clause",
      "text": "Foreign sponsor's domestic agent must be identified in IND with defined responsibilities",
      "section": "drug imports",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK85-REQ-005",
      "type": "clause",
      "text": "Exported investigational drugs must comply with receiving country's laws",
      "section": "drug exports",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK85-REQ-006",
      "type": "clause",
      "text": "Recipients of exported drugs must be investigators in an approved IND study",
      "section": "drug exports",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK86-REQ-001",
      "type": "clause",
      "text": "Drug exports to EU/EEA and specified countries must comply with the importing country's laws",
      "section": "drug export compliance",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK86-REQ-002",
      "type": "clause",
      "text": "Exported drugs not under IND are exempt from label requirements in \u00a7 312.6(a)",
      "section": "labeling exemptions",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK86-REQ-003",
      "type": "clause",
      "text": "Exporters must send certification email to OGPSExecSec@fda.hhs.gov when drug is first exported",
      "section": "export certification",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK86-REQ-004",
      "type": "clause",
      "text": "Export certification must include drug trade name, generic name, and dosage form",
      "section": "export documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK86-REQ-005",
      "type": "clause",
      "text": "Exporters must maintain records documenting compliance with certification requirements",
      "section": "record keeping",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK86-REQ-006",
      "type": "clause",
      "text": "Exported drug must meet foreign purchaser's or consignee's specifications",
      "section": "product specifications",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK87-REQ-001",
      "type": "clause",
      "text": "Outer shipping package must be labeled to indicate package is for export from US",
      "section": "labeling",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK87-REQ-002",
      "type": "clause",
      "text": "Drug must not be sold or offered for sale in the United States",
      "section": "distribution control",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK87-REQ-003",
      "type": "clause",
      "text": "Clinical investigation must be conducted in accordance with \u00a7 312.120",
      "section": "clinical compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK87-REQ-004",
      "type": "clause",
      "text": "Drug must be manufactured and handled in conformity with current good manufacturing practices",
      "section": "manufacturing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK87-REQ-005",
      "type": "clause",
      "text": "Drug must not present imminent hazard to public health in US or foreign country",
      "section": "safety",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK87-REQ-006",
      "type": "clause",
      "text": "Drug must be labeled in accordance with foreign country's laws",
      "section": "labeling",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK88-REQ-001",
      "type": "clause",
      "text": "Provide written statement explaining why compliance with specified paragraphs is not feasible",
      "section": "export documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK88-REQ-002",
      "type": "clause",
      "text": "Obtain written statement from importing country's government official agreeing with exporter's statement",
      "section": "export authorization",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK88-REQ-003",
      "type": "clause",
      "text": "Official statement must confirm drug is for national emergency stockpile use only",
      "section": "export authorization",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK88-REQ-004",
      "type": "clause",
      "text": "Official statement must describe the potential national emergency warranting the export",
      "section": "export authorization",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK88-REQ-005",
      "type": "clause",
      "text": "Obtain written statement showing Secretary of HHS agrees with importing country's findings",
      "section": "export authorization",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK88-REQ-006",
      "type": "clause",
      "text": "Direct requests for Secretary's statement to Secretary's Operations Center",
      "section": "administrative procedure",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK89-REQ-001",
      "type": "clause",
      "text": "Export requests may be sent to HHS by fax at 202-619-7870",
      "section": "export request submission",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK89-REQ-002",
      "type": "clause",
      "text": "Export requests may be sent to HHS by email at HHS.SOC@hhs.gov",
      "section": "export request submission",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK89-REQ-003",
      "type": "clause",
      "text": "FDA authorization must be obtained before exporting investigational new drugs",
      "section": "export authorization",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK89-REQ-004",
      "type": "clause",
      "text": "For emergency exports, provide written statement explaining why compliance with requirements is not feasible",
      "section": "emergency export process",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK89-REQ-005",
      "type": "clause",
      "text": "For emergency exports, provide documentation from importing country's government official",
      "section": "emergency export documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK90-REQ-001",
      "type": "clause",
      "text": "Requests for emergency drug export determinations must be sent to the Secretary's Operations Center",
      "section": "export requests",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK90-REQ-002",
      "type": "clause",
      "text": "Export requests may be submitted by FAX to 202-619-7870",
      "section": "export requests",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK90-REQ-003",
      "type": "clause",
      "text": "Export requests may be submitted by email to HHS.SOC@hhs.gov",
      "section": "export requests",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK90-REQ-004",
      "type": "clause",
      "text": "Drug exports must not occur if the IND for the clinical investigation is no longer in effect",
      "section": "export restrictions",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK90-REQ-005",
      "type": "clause",
      "text": "Drug exports must not occur if requirements in section 802(b)(1), (f), or (g) are no longer met",
      "section": "export restrictions",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK91-REQ-001",
      "type": "clause",
      "text": "FDA must accept well-designed foreign clinical studies not conducted under IND as support for marketing approval",
      "section": "clinical studies acceptance",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK91-REQ-002",
      "type": "clause",
      "text": "Foreign clinical studies must be conducted in accordance with Good Clinical Practice (GCP)",
      "section": "clinical study standards",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK91-REQ-003",
      "type": "clause",
      "text": "GCP must ensure data and results are credible and accurate",
      "section": "data integrity",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK91-REQ-004",
      "type": "clause",
      "text": "GCP must protect rights, safety and well-being of trial subjects",
      "section": "subject protection",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK91-REQ-005",
      "type": "clause",
      "text": "New insulin and antibiotic products may be exported for investigational use under section 801(e)(1)",
      "section": "drug export",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK91-REQ-006",
      "type": "clause",
      "text": "Investigational drugs must comply with importing country laws",
      "section": "regulatory compliance",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK92-REQ-001",
      "type": "clause",
      "text": "Obtain independent ethics committee approval before initiating a study",
      "section": "ethics approval",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK92-REQ-002",
      "type": "clause",
      "text": "Ethics committee must conduct continuing review of ongoing studies",
      "section": "ethics oversight",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK92-REQ-003",
      "type": "clause",
      "text": "Obtain documented informed consent from subject or legal representative before study initiation",
      "section": "informed consent",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK92-REQ-004",
      "type": "clause",
      "text": "FDA may validate study data through onsite inspection if deemed necessary",
      "section": "data validation",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK92-REQ-005",
      "type": "clause",
      "text": "Studies not meeting conditions in paragraph (a)(1) cannot be used to support IND or marketing approval",
      "section": "study acceptance",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK92-REQ-006",
      "type": "clause",
      "text": "Marketing approval based solely on foreign clinical data must comply with \u00a7 314.106",
      "section": "foreign data acceptance",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK93-REQ-001",
      "type": "clause",
      "text": "Submit description of actions taken to ensure research conformed to GCP",
      "section": "compliance documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK93-REQ-002",
      "type": "clause",
      "text": "Submit investigator qualifications documentation",
      "section": "personnel documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK93-REQ-003",
      "type": "clause",
      "text": "Submit description of research facilities",
      "section": "facility documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK93-REQ-004",
      "type": "clause",
      "text": "Submit detailed protocol summary and study results",
      "section": "study documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK93-REQ-005",
      "type": "clause",
      "text": "Submit description of drug substance and product used including components and specifications",
      "section": "product documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK93-REQ-006",
      "type": "clause",
      "text": "Submit proof study is adequate and well controlled if supporting drug effectiveness",
      "section": "study validation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK93-REQ-007",
      "type": "clause",
      "text": "Submit name and address of IEC that reviewed the study",
      "section": "ethics documentation",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-001",
      "type": "clause",
      "text": "Sponsor must maintain records of IEC members' names and qualifications",
      "section": "record keeping",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-002",
      "type": "clause",
      "text": "Sponsor must make IEC member records available for agency review upon request",
      "section": "regulatory compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-003",
      "type": "clause",
      "text": "Study must include summary of IEC's decision to approve or modify and approve the study",
      "section": "study documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-004",
      "type": "clause",
      "text": "Study must document how informed consent was obtained from participants",
      "section": "informed consent",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK94-REQ-005",
      "type": "clause",
      "text": "Study must describe any incentives provided to study participants",
      "section": "study documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK94-REQ-006",
      "type": "clause",
      "text": "Sponsor must document how study monitoring ensured protocol compliance",
      "section": "study monitoring",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-007",
      "type": "clause",
      "text": "Sponsor must maintain signed investigator commitments to GCP compliance",
      "section": "investigator compliance",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK94-REQ-008",
      "type": "clause",
      "text": "Sponsor must make investigator GCP commitments available for agency review upon request",
      "section": "regulatory compliance",
      "clause_number": "REQ-008",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK95-REQ-001",
      "type": "clause",
      "text": "Sponsors may request waivers from FDA for applicable requirements in paragraphs (a)(1) and (b)",
      "section": "waivers",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK95-REQ-002",
      "type": "clause",
      "text": "Waiver requests must include explanation of why compliance is unnecessary or unachievable",
      "section": "waiver documentation",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK95-REQ-003",
      "type": "clause",
      "text": "Waiver requests must describe alternative actions that satisfy the requirement's purpose",
      "section": "waiver documentation",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK95-REQ-004",
      "type": "clause",
      "text": "FDA may grant waivers if determined to be in the interest of public health",
      "section": "waiver approval",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK95-REQ-005",
      "type": "clause",
      "text": "Records for foreign clinical studies supporting marketing approval must be retained for 2 years after agency decision",
      "section": "record retention",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK95-REQ-006",
      "type": "clause",
      "text": "Records for foreign clinical studies supporting only INDs must be retained for 2 years after IND submission",
      "section": "record retention",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK96-REQ-001",
      "type": "clause",
      "text": "FDA shall not disclose existence of investigational new drug applications unless previously publicly disclosed",
      "section": "confidentiality",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK96-REQ-002",
      "type": "clause",
      "text": "Data disclosure for new drug INDs must follow confidentiality provisions in \u00a7 314.430",
      "section": "data disclosure",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK96-REQ-003",
      "type": "clause",
      "text": "Data disclosure for biological product INDs must follow provisions in \u00a7\u00a7 601.50 and 601.51",
      "section": "data disclosure",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK96-REQ-004",
      "type": "clause",
      "text": "FDA shall provide IND safety reports to individuals who received the investigational drug upon request",
      "section": "safety reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK96-REQ-005",
      "type": "clause",
      "text": "Requests for public IND info under informed consent exceptions must be submitted via Freedom of Information Act",
      "section": "information requests",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK97-REQ-001",
      "type": "clause",
      "text": "Send initial IND submissions for CDER-regulated drug products to the Central Document Room in Beltsville, MD",
      "section": "submission routing",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK97-REQ-002",
      "type": "clause",
      "text": "Send initial IND submissions for CDER-regulated biological products to the Central Document Room in Beltsville, MD",
      "section": "submission routing",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK97-REQ-003",
      "type": "clause",
      "text": "Send initial IND submissions for CBER-regulated biological products to the Document Control Center in FDA",
      "section": "submission routing",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK97-REQ-004",
      "type": "clause",
      "text": "Submit initial IND to either CDER or CBER based on which Center regulates the product",
      "section": "submission routing",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK98-REQ-001",
      "type": "clause",
      "text": "The responsible Center must inform sponsors which CDER/CBER division is responsible for their IND",
      "section": "IND processing",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK98-REQ-002",
      "type": "clause",
      "text": "IND amendments and reports must be sent to the appropriate center and marked for the responsible division",
      "section": "submission routing",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK98-REQ-003",
      "type": "clause",
      "text": "The outside wrapper of each submission shall state the content type (e.g. 'IND Application', 'Protocol Amendment')",
      "section": "submission labeling",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK98-REQ-004",
      "type": "clause",
      "text": "Export-related IND correspondence shall be submitted to the International Affairs Staff at the specified address",
      "section": "export submissions",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK98-REQ-005",
      "type": "clause",
      "text": "FDA provides guidance documents to help comply with requirements",
      "section": "guidance documents",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK98-REQ-006",
      "type": "clause",
      "text": "CDER and CBER must maintain lists of applicable guidance documents on the Internet",
      "section": "guidance documents",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK98-REQ-007",
      "type": "clause",
      "text": "Guidance document lists must be published annually in the Federal Register",
      "section": "guidance documents",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK99-REQ-001",
      "type": "clause",
      "text": "Label investigational drugs for laboratory research with 'Not for use in humans' warning",
      "section": "labeling",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK99-REQ-002",
      "type": "clause",
      "text": "Label biological products for in vitro diagnostic tests with appropriate caution statement",
      "section": "labeling",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK99-REQ-003",
      "type": "clause",
      "text": "Verify consignee regularly conducts laboratory research tests before shipping",
      "section": "shipping verification",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK99-REQ-004",
      "type": "clause",
      "text": "Ensure shipped investigational drugs will only be used for in vitro or animal laboratory research",
      "section": "usage control",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK99-REQ-005",
      "type": "clause",
      "text": "Request CBER list copies from FDA Center for Biologics Evaluation and Research office",
      "section": "documentation",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "low"
    },
    {
      "id": "FDA-CHUNK100-REQ-001",
      "type": "clause",
      "text": "Maintain records showing name and address of experts receiving drug shipments",
      "section": "record keeping",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK100-REQ-002",
      "type": "clause",
      "text": "Keep records of shipment date, quantity and batch/code mark for each delivery",
      "section": "record keeping",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK100-REQ-003",
      "type": "clause",
      "text": "Maintain paragraph (a)(1)(i) shipment records for 2 years",
      "section": "record retention",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK100-REQ-004",
      "type": "clause",
      "text": "Allow FDA officers to access and verify shipment records upon request",
      "section": "regulatory inspection",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK100-REQ-005",
      "type": "clause",
      "text": "FDA may terminate shipping authorization if sponsor fails to comply with conditions",
      "section": "compliance enforcement",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK100-REQ-006",
      "type": "clause",
      "text": "FDA must notify shipper of compliance findings and allow correction opportunity",
      "section": "compliance enforcement",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK101-REQ-001",
      "type": "clause",
      "text": "Drug shipper shall ensure return of all unused drug supplies from investigators when investigation ends or terminates",
      "section": "drug disposition",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK101-REQ-002",
      "type": "clause",
      "text": "Alternative disposition of unused drugs requires written authorization from the shipper",
      "section": "drug disposition",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK101-REQ-003",
      "type": "clause",
      "text": "Alternative drug disposition must not expose humans to risks directly or indirectly",
      "section": "drug safety",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK101-REQ-004",
      "type": "clause",
      "text": "Shipper shall maintain records of any alternative drug disposition",
      "section": "recordkeeping",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK101-REQ-005",
      "type": "clause",
      "text": "Expanded access requirements apply to investigational new drugs and approved drugs with limited REMS availability",
      "section": "scope",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK102-REQ-001",
      "type": "clause",
      "text": "FDA must determine if patients have a serious or immediately life-threatening disease or condition",
      "section": "patient eligibility",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK102-REQ-002",
      "type": "clause",
      "text": "FDA must verify no comparable or satisfactory alternative therapy exists for the disease/condition",
      "section": "treatment alternatives",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK102-REQ-003",
      "type": "clause",
      "text": "Immediately life-threatening conditions must have likelihood of death within months or premature death without treatment",
      "section": "condition definitions",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK102-REQ-004",
      "type": "clause",
      "text": "Serious diseases/conditions must substantially impact day-to-day functioning with persistent/recurrent morbidity",
      "section": "condition definitions",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK102-REQ-005",
      "type": "clause",
      "text": "Clinical judgment must determine disease seriousness based on survival, functioning and progression factors",
      "section": "clinical assessment",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK103-REQ-001",
      "type": "clause",
      "text": "Patient benefit must justify potential risks of treatment use",
      "section": "risk assessment",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK103-REQ-002",
      "type": "clause",
      "text": "Expanded access must not interfere with clinical investigations for marketing approval",
      "section": "clinical trials",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK103-REQ-003",
      "type": "clause",
      "text": "Submit expanded access request as new IND or protocol amendment to existing IND",
      "section": "submission process",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK103-REQ-004",
      "type": "clause",
      "text": "Include FDA Form 1571 cover sheet with expanded access submission",
      "section": "documentation",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK103-REQ-005",
      "type": "clause",
      "text": "Provide rationale for drug use including list of available therapeutic options",
      "section": "documentation",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK103-REQ-006",
      "type": "clause",
      "text": "Explain why investigational drug is preferable to available therapeutic options",
      "section": "documentation",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK104-REQ-001",
      "type": "clause",
      "text": "Patient selection criteria must be documented for expanded access submissions",
      "section": "patient documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK104-REQ-002",
      "type": "clause",
      "text": "Drug administration method, dose and therapy duration must be specified",
      "section": "drug administration",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK104-REQ-003",
      "type": "clause",
      "text": "Manufacturing facility details must be described in submission",
      "section": "manufacturing",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK104-REQ-004",
      "type": "clause",
      "text": "Chemistry and controls information must ensure proper drug identification and quality",
      "section": "quality control",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK104-REQ-005",
      "type": "clause",
      "text": "Submissions must be clearly marked 'EXPANDED ACCESS SUBMISSION' on mailing cover",
      "section": "submission labeling",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK104-REQ-006",
      "type": "clause",
      "text": "Treatment IND/protocol box on Form FDA 1571 must be checked if applicable",
      "section": "form completion",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK104-REQ-007",
      "type": "clause",
      "text": "Clinical procedures and monitoring methods must be described to evaluate drug effects",
      "section": "clinical monitoring",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-001",
      "type": "clause",
      "text": "Licensed physicians administering investigational drugs under expanded access are considered investigators",
      "section": "roles and responsibilities",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK105-REQ-002",
      "type": "clause",
      "text": "Entities submitting expanded access INDs must comply with sponsor responsibilities in subpart D",
      "section": "regulatory compliance",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-003",
      "type": "clause",
      "text": "Physicians submitting expanded access INDs must comply with sponsor-investigator responsibilities",
      "section": "regulatory compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-004",
      "type": "clause",
      "text": "Investigators must report adverse drug events to the sponsor",
      "section": "adverse event reporting",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-005",
      "type": "clause",
      "text": "Investigators must ensure informed consent requirements are met per part 50",
      "section": "informed consent",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-006",
      "type": "clause",
      "text": "Investigators must obtain IRB review for expanded access use per part 56",
      "section": "IRB review",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK105-REQ-007",
      "type": "clause",
      "text": "Investigators must maintain accurate case histories",
      "section": "documentation",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK106-REQ-001",
      "type": "clause",
      "text": "Licensed physicians must be qualified to administer investigational drugs for expanded access use",
      "section": "physician qualifications",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK106-REQ-002",
      "type": "clause",
      "text": "Sponsors must submit IND safety reports to FDA",
      "section": "safety reporting",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK106-REQ-003",
      "type": "clause",
      "text": "Sponsors must submit annual reports when IND/protocol continues for 1+ year",
      "section": "periodic reporting",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK106-REQ-004",
      "type": "clause",
      "text": "Sponsors must provide physicians with investigator brochure if one exists",
      "section": "physician information",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK106-REQ-005",
      "type": "clause",
      "text": "Sponsors must maintain drug disposition records",
      "section": "record keeping",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK106-REQ-006",
      "type": "clause",
      "text": "FDA may permit investigational drug use for individual patient treatment by licensed physician",
      "section": "expanded access",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK107-REQ-001",
      "type": "clause",
      "text": "Expanded access IND becomes effective 30 days after FDA receipt or earlier FDA notification",
      "section": "IND timeline",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK107-REQ-002",
      "type": "clause",
      "text": "Emergency expanded access use may only begin when authorized by FDA reviewing official",
      "section": "emergency access",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK107-REQ-003",
      "type": "clause",
      "text": "FDA may place any expanded access IND or protocol on clinical hold",
      "section": "clinical holds",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK107-REQ-004",
      "type": "clause",
      "text": "Physician must determine probable drug risk is not greater than disease risk",
      "section": "risk assessment",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK107-REQ-005",
      "type": "clause",
      "text": "FDA must determine patient cannot obtain drug under another IND/protocol",
      "section": "access criteria",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK107-REQ-006",
      "type": "clause",
      "text": "Expanded access submission must demonstrate criteria compliance with supporting information",
      "section": "submission requirements",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK108-REQ-001",
      "type": "clause",
      "text": "Sponsors may amend existing IND to include protocol for individual patient expanded access",
      "section": "IND submission",
      "clause_number": "REQ-001",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK108-REQ-002",
      "type": "clause",
      "text": "FDA may permit investigational drug use for smaller patient populations than typical treatment IND",
      "section": "expanded access",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK108-REQ-003",
      "type": "clause",
      "text": "Licensed physicians must obtain sponsor permission for FDA to reference IND information",
      "section": "right of reference",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK108-REQ-004",
      "type": "clause",
      "text": "Treatment is limited to single course unless FDA authorizes multiple/chronic therapy",
      "section": "treatment limitations",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK108-REQ-005",
      "type": "clause",
      "text": "Licensed physician or sponsor must provide FDA written report at treatment conclusion",
      "section": "reporting",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK109-REQ-001",
      "type": "clause",
      "text": "Sponsors must provide a summary of expanded access use results including adverse effects",
      "section": "reporting",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK109-REQ-002",
      "type": "clause",
      "text": "FDA may require sponsors to monitor individual patient expanded access for extended duration use",
      "section": "patient monitoring",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK109-REQ-003",
      "type": "clause",
      "text": "Emergency expanded access requests can be made by phone, fax or electronic communications",
      "section": "emergency procedures",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK109-REQ-004",
      "type": "clause",
      "text": "Biologics emergency requests must be directed to CBER Office of Communication at specified contacts",
      "section": "emergency contacts",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK109-REQ-005",
      "type": "clause",
      "text": "Non-biologics emergency requests must be directed to CDER Division of Drug Information",
      "section": "emergency contacts",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK109-REQ-006",
      "type": "clause",
      "text": "After-hours emergency requests must be directed to FDA Emergency Call Center",
      "section": "emergency contacts",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK110-REQ-001",
      "type": "clause",
      "text": "Licensed physician or sponsor must explain how expanded access use meets requirements of \u00a7\u00a7 312.305 and 312.310",
      "section": "expanded access documentation",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK110-REQ-002",
      "type": "clause",
      "text": "Submit expanded access submission within 15 working days of FDA authorization",
      "section": "submission timelines",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK110-REQ-003",
      "type": "clause",
      "text": "Expanded access may be granted for drugs not being developed due to rare disease recruitment challenges",
      "section": "expanded access eligibility",
      "clause_number": "REQ-003",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK110-REQ-004",
      "type": "clause",
      "text": "Expanded access may be granted when patients cannot participate in existing clinical trials",
      "section": "expanded access eligibility",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK110-REQ-005",
      "type": "clause",
      "text": "Expanded access may be granted for approved drugs no longer marketed for safety reasons",
      "section": "expanded access eligibility",
      "clause_number": "REQ-005",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK110-REQ-006",
      "type": "clause",
      "text": "Expanded access may be granted for drugs with same active moiety as unavailable approved products",
      "section": "expanded access eligibility",
      "clause_number": "REQ-006",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK111-REQ-001",
      "type": "clause",
      "text": "The criteria in \u00a7 312.305(a) must be met for expanded access",
      "section": "expanded access criteria",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK111-REQ-002",
      "type": "clause",
      "text": "Evidence must show drug safety at proposed dose/duration to justify clinical trial",
      "section": "drug safety evidence",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK111-REQ-003",
      "type": "clause",
      "text": "Preliminary clinical evidence of drug effectiveness must be available",
      "section": "drug effectiveness",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK111-REQ-004",
      "type": "clause",
      "text": "Expanded access submission must meet requirements of \u00a7 312.305(b)",
      "section": "submission requirements",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK111-REQ-005",
      "type": "clause",
      "text": "Submission must state if drug is being developed and describe patient population",
      "section": "submission content",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK111-REQ-006",
      "type": "clause",
      "text": "Sponsor must explain why undeveloped drug cannot be developed for expanded access",
      "section": "development justification",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK111-REQ-007",
      "type": "clause",
      "text": "Sponsor must explain why clinical trial patients need expanded access treatment",
      "section": "access justification",
      "clause_number": "REQ-007",
      "requirement_type": "mandatory",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK112-REQ-001",
      "type": "clause",
      "text": "FDA must determine if expanded access should continue based on annual report review",
      "section": "expanded access review",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK112-REQ-002",
      "type": "clause",
      "text": "FDA may permit investigational drugs for widespread treatment use",
      "section": "treatment IND",
      "clause_number": "REQ-002",
      "requirement_type": "recommended",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK112-REQ-003",
      "type": "clause",
      "text": "Sponsors must monitor expanded access protocols to ensure physician compliance",
      "section": "protocol compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK112-REQ-004",
      "type": "clause",
      "text": "FDA may request sponsor submit IND/protocol as patient enrollment increases",
      "section": "IND submission",
      "clause_number": "REQ-004",
      "requirement_type": "recommended",
      "severity": "medium"
    },
    {
      "id": "FDA-CHUNK112-REQ-005",
      "type": "clause",
      "text": "FDA must evaluate if expanded access interferes with clinical development",
      "section": "development impact",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK112-REQ-006",
      "type": "clause",
      "text": "Criteria in section 312.305(a) must be met for treatment IND approval",
      "section": "approval criteria",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK113-REQ-001",
      "type": "clause",
      "text": "Drug must be investigated in controlled clinical trial under IND for expanded access use",
      "section": "clinical trials",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK113-REQ-002",
      "type": "clause",
      "text": "Sponsor must actively pursue marketing approval for expanded access use with due diligence",
      "section": "marketing approval",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK113-REQ-003",
      "type": "clause",
      "text": "For serious diseases, sufficient clinical evidence must include data from phase 3 or compelling phase 2 trials",
      "section": "clinical evidence",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK113-REQ-004",
      "type": "clause",
      "text": "For life-threatening diseases, evidence must show drug may be effective without unreasonable risk",
      "section": "safety evidence",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK113-REQ-005",
      "type": "clause",
      "text": "Expanded access submission must include information proving criteria in 312.305(a) are met",
      "section": "submission requirements",
      "clause_number": "REQ-005",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK113-REQ-006",
      "type": "clause",
      "text": "Expanded access submission must meet requirements of 312.305(b)",
      "section": "submission requirements",
      "clause_number": "REQ-006",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK114-REQ-001",
      "type": "clause",
      "text": "Sponsors must monitor treatment protocols to ensure physician compliance",
      "section": "protocol monitoring",
      "clause_number": "REQ-001",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK114-REQ-002",
      "type": "clause",
      "text": "Sponsors must ensure licensed physicians follow the treatment protocol",
      "section": "physician oversight",
      "clause_number": "REQ-002",
      "requirement_type": "mandatory",
      "severity": "high"
    },
    {
      "id": "FDA-CHUNK114-REQ-003",
      "type": "clause",
      "text": "Sponsors must verify physicians comply with investigator regulations",
      "section": "regulatory compliance",
      "clause_number": "REQ-003",
      "requirement_type": "mandatory",
      "severity": "critical"
    },
    {
      "id": "FDA-CHUNK114-REQ-004",
      "type": "clause",
      "text": "Only licensed physicians may conduct treatment under the protocol",
      "section": "physician qualifications",
      "clause_number": "REQ-004",
      "requirement_type": "mandatory",
      "severity": "critical"
    }
  ],
  "edges": [
    {
      "source": "FDA-CHUNK0-REQ-001",
      "target": "FDA-CHUNK0-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-001",
      "target": "FDA-CHUNK1-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-002",
      "target": "FDA-CHUNK0-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-003",
      "target": "FDA-CHUNK0-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-004",
      "target": "FDA-CHUNK0-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-005",
      "target": "FDA-CHUNK0-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-005",
      "target": "FDA-CHUNK1-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK0-REQ-006",
      "target": "FDA-CHUNK1-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-001",
      "target": "FDA-CHUNK1-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-001",
      "target": "FDA-CHUNK1-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-002",
      "target": "FDA-CHUNK1-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-002",
      "target": "FDA-CHUNK1-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-003",
      "target": "FDA-CHUNK1-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-003",
      "target": "FDA-CHUNK0-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-004",
      "target": "FDA-CHUNK1-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-005",
      "target": "FDA-CHUNK1-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-005",
      "target": "FDA-CHUNK2-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK1-REQ-006",
      "target": "FDA-CHUNK2-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-001",
      "target": "FDA-CHUNK2-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-001",
      "target": "FDA-CHUNK2-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-002",
      "target": "FDA-CHUNK2-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-003",
      "target": "FDA-CHUNK2-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-004",
      "target": "FDA-CHUNK2-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-005",
      "target": "FDA-CHUNK3-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-005",
      "target": "FDA-CHUNK2-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-006",
      "target": "FDA-CHUNK2-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-007",
      "target": "FDA-CHUNK3-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-007",
      "target": "FDA-CHUNK2-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-001",
      "target": "FDA-CHUNK3-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-002",
      "target": "FDA-CHUNK3-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-003",
      "target": "FDA-CHUNK3-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-004",
      "target": "FDA-CHUNK3-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-004",
      "target": "FDA-CHUNK3-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-005",
      "target": "FDA-CHUNK4-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-005",
      "target": "FDA-CHUNK3-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-005",
      "target": "FDA-CHUNK3-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-001",
      "target": "FDA-CHUNK4-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-002",
      "target": "FDA-CHUNK4-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-003",
      "target": "FDA-CHUNK4-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-004",
      "target": "FDA-CHUNK4-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-005",
      "target": "FDA-CHUNK5-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-005",
      "target": "FDA-CHUNK4-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-001",
      "target": "FDA-CHUNK5-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-002",
      "target": "FDA-CHUNK5-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-003",
      "target": "FDA-CHUNK8-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-003",
      "target": "FDA-CHUNK5-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-004",
      "target": "FDA-CHUNK8-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-004",
      "target": "FDA-CHUNK5-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-005",
      "target": "FDA-CHUNK5-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-005",
      "target": "FDA-CHUNK6-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK5-REQ-006",
      "target": "FDA-CHUNK6-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-001",
      "target": "FDA-CHUNK6-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-001",
      "target": "FDA-CHUNK6-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-002",
      "target": "FDA-CHUNK6-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-003",
      "target": "FDA-CHUNK8-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-003",
      "target": "FDA-CHUNK6-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-004",
      "target": "FDA-CHUNK6-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-005",
      "target": "FDA-CHUNK6-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK6-REQ-006",
      "target": "FDA-CHUNK7-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-001",
      "target": "FDA-CHUNK7-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-002",
      "target": "FDA-CHUNK7-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-003",
      "target": "FDA-CHUNK7-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-004",
      "target": "FDA-CHUNK7-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-005",
      "target": "FDA-CHUNK7-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK7-REQ-006",
      "target": "FDA-CHUNK8-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-001",
      "target": "FDA-CHUNK8-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-002",
      "target": "FDA-CHUNK8-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-003",
      "target": "FDA-CHUNK8-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-003",
      "target": "FDA-CHUNK8-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-004",
      "target": "FDA-CHUNK8-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-005",
      "target": "FDA-CHUNK8-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-005",
      "target": "FDA-CHUNK9-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-006",
      "target": "FDA-CHUNK8-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-006",
      "target": "FDA-CHUNK9-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK8-REQ-007",
      "target": "FDA-CHUNK9-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-001",
      "target": "FDA-CHUNK9-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-002",
      "target": "FDA-CHUNK9-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-003",
      "target": "FDA-CHUNK9-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-004",
      "target": "FDA-CHUNK9-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-005",
      "target": "FDA-CHUNK9-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK9-REQ-006",
      "target": "FDA-CHUNK10-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-001",
      "target": "FDA-CHUNK12-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-001",
      "target": "FDA-CHUNK10-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-001",
      "target": "FDA-CHUNK10-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-002",
      "target": "FDA-CHUNK10-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-003",
      "target": "FDA-CHUNK10-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-004",
      "target": "FDA-CHUNK10-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-005",
      "target": "FDA-CHUNK10-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-005",
      "target": "FDA-CHUNK11-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-006",
      "target": "FDA-CHUNK11-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-006",
      "target": "FDA-CHUNK10-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-001",
      "target": "FDA-CHUNK13-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-001",
      "target": "FDA-CHUNK11-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-002",
      "target": "FDA-CHUNK11-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-003",
      "target": "FDA-CHUNK11-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-004",
      "target": "FDA-CHUNK11-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-005",
      "target": "FDA-CHUNK12-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-005",
      "target": "FDA-CHUNK11-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-001",
      "target": "FDA-CHUNK14-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-001",
      "target": "FDA-CHUNK12-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-002",
      "target": "FDA-CHUNK12-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-003",
      "target": "FDA-CHUNK12-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-003",
      "target": "FDA-CHUNK12-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-004",
      "target": "FDA-CHUNK12-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-005",
      "target": "FDA-CHUNK12-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-006",
      "target": "FDA-CHUNK13-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-006",
      "target": "FDA-CHUNK12-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-001",
      "target": "FDA-CHUNK13-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-001",
      "target": "FDA-CHUNK14-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-001",
      "target": "FDA-CHUNK13-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-002",
      "target": "FDA-CHUNK13-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-002",
      "target": "FDA-CHUNK14-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-003",
      "target": "FDA-CHUNK13-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-003",
      "target": "FDA-CHUNK14-REQ-002",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-004",
      "target": "FDA-CHUNK15-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-004",
      "target": "FDA-CHUNK13-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-004",
      "target": "FDA-CHUNK14-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-005",
      "target": "FDA-CHUNK13-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-006",
      "target": "FDA-CHUNK14-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-006",
      "target": "FDA-CHUNK13-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-001",
      "target": "FDA-CHUNK14-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-001",
      "target": "FDA-CHUNK14-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-002",
      "target": "FDA-CHUNK14-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-003",
      "target": "FDA-CHUNK14-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-004",
      "target": "FDA-CHUNK14-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-005",
      "target": "FDA-CHUNK14-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-006",
      "target": "FDA-CHUNK15-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-006",
      "target": "FDA-CHUNK13-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-006",
      "target": "FDA-CHUNK14-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-001",
      "target": "FDA-CHUNK15-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-001",
      "target": "FDA-CHUNK14-REQ-008",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-002",
      "target": "FDA-CHUNK15-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-002",
      "target": "FDA-CHUNK19-REQ-002",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-003",
      "target": "FDA-CHUNK15-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-004",
      "target": "FDA-CHUNK15-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-005",
      "target": "FDA-CHUNK16-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-005",
      "target": "FDA-CHUNK15-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-001",
      "target": "FDA-CHUNK15-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.87,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-001",
      "target": "FDA-CHUNK16-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-001",
      "target": "FDA-CHUNK17-REQ-002",
      "relation": "RELATED_TO",
      "confidence": 0.82,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-002",
      "target": "FDA-CHUNK16-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-003",
      "target": "FDA-CHUNK16-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-004",
      "target": "FDA-CHUNK16-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-005",
      "target": "FDA-CHUNK16-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-005",
      "target": "FDA-CHUNK17-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-006",
      "target": "FDA-CHUNK17-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-006",
      "target": "FDA-CHUNK16-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-001",
      "target": "FDA-CHUNK17-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-002",
      "target": "FDA-CHUNK17-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-003",
      "target": "FDA-CHUNK17-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-004",
      "target": "FDA-CHUNK17-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-005",
      "target": "FDA-CHUNK17-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-005",
      "target": "FDA-CHUNK18-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-006",
      "target": "FDA-CHUNK17-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-006",
      "target": "FDA-CHUNK18-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK17-REQ-007",
      "target": "FDA-CHUNK18-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-001",
      "target": "FDA-CHUNK18-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-001",
      "target": "FDA-CHUNK17-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-002",
      "target": "FDA-CHUNK18-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-003",
      "target": "FDA-CHUNK18-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-004",
      "target": "FDA-CHUNK18-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-005",
      "target": "FDA-CHUNK18-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-005",
      "target": "FDA-CHUNK16-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.88,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-006",
      "target": "FDA-CHUNK19-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-006",
      "target": "FDA-CHUNK18-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-001",
      "target": "FDA-CHUNK19-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.83,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-001",
      "target": "FDA-CHUNK19-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-002",
      "target": "FDA-CHUNK19-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-002",
      "target": "FDA-CHUNK19-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-003",
      "target": "FDA-CHUNK19-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-004",
      "target": "FDA-CHUNK19-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-005",
      "target": "FDA-CHUNK19-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-006",
      "target": "FDA-CHUNK19-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-006",
      "target": "FDA-CHUNK20-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK19-REQ-007",
      "target": "FDA-CHUNK20-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-001",
      "target": "FDA-CHUNK20-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-002",
      "target": "FDA-CHUNK20-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-003",
      "target": "FDA-CHUNK20-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-004",
      "target": "FDA-CHUNK20-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-005",
      "target": "FDA-CHUNK20-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-006",
      "target": "FDA-CHUNK20-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-006",
      "target": "FDA-CHUNK21-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-007",
      "target": "FDA-CHUNK20-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.75,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK20-REQ-007",
      "target": "FDA-CHUNK21-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-001",
      "target": "FDA-CHUNK21-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-001",
      "target": "FDA-CHUNK21-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-002",
      "target": "FDA-CHUNK21-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-002",
      "target": "FDA-CHUNK21-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-003",
      "target": "FDA-CHUNK21-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-003",
      "target": "FDA-CHUNK21-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-004",
      "target": "FDA-CHUNK21-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-004",
      "target": "FDA-CHUNK21-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-005",
      "target": "FDA-CHUNK21-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-006",
      "target": "FDA-CHUNK21-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-006",
      "target": "FDA-CHUNK22-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK21-REQ-007",
      "target": "FDA-CHUNK22-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK2-REQ-008",
      "target": "FDA-CHUNK3-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-006",
      "target": "FDA-CHUNK3-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-006",
      "target": "FDA-CHUNK4-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK3-REQ-007",
      "target": "FDA-CHUNK4-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK4-REQ-006",
      "target": "FDA-CHUNK5-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK11-REQ-006",
      "target": "FDA-CHUNK12-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-007",
      "target": "FDA-CHUNK15-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-007",
      "target": "FDA-CHUNK14-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-006",
      "target": "FDA-CHUNK15-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK15-REQ-007",
      "target": "FDA-CHUNK16-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-007",
      "target": "FDA-CHUNK16-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK16-REQ-008",
      "target": "FDA-CHUNK17-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-001",
      "target": "FDA-CHUNK22-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-002",
      "target": "FDA-CHUNK22-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-003",
      "target": "FDA-CHUNK22-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-004",
      "target": "FDA-CHUNK22-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-005",
      "target": "FDA-CHUNK22-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK22-REQ-006",
      "target": "FDA-CHUNK23-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-001",
      "target": "FDA-CHUNK23-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-001",
      "target": "FDA-CHUNK23-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-002",
      "target": "FDA-CHUNK23-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-003",
      "target": "FDA-CHUNK23-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-004",
      "target": "FDA-CHUNK23-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-005",
      "target": "FDA-CHUNK23-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-005",
      "target": "FDA-CHUNK24-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-006",
      "target": "FDA-CHUNK23-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK23-REQ-007",
      "target": "FDA-CHUNK24-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-001",
      "target": "FDA-CHUNK24-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-002",
      "target": "FDA-CHUNK24-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-003",
      "target": "FDA-CHUNK24-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-004",
      "target": "FDA-CHUNK24-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-005",
      "target": "FDA-CHUNK24-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-005",
      "target": "FDA-CHUNK25-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-006",
      "target": "FDA-CHUNK25-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-006",
      "target": "FDA-CHUNK24-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-001",
      "target": "FDA-CHUNK24-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-001",
      "target": "FDA-CHUNK25-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-002",
      "target": "FDA-CHUNK25-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-003",
      "target": "FDA-CHUNK25-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-004",
      "target": "FDA-CHUNK25-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-005",
      "target": "FDA-CHUNK25-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-005",
      "target": "FDA-CHUNK27-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK25-REQ-006",
      "target": "FDA-CHUNK26-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-001",
      "target": "FDA-CHUNK26-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-002",
      "target": "FDA-CHUNK26-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-003",
      "target": "FDA-CHUNK26-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-004",
      "target": "FDA-CHUNK26-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-005",
      "target": "FDA-CHUNK26-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-006",
      "target": "FDA-CHUNK26-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-001",
      "target": "FDA-CHUNK28-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-001",
      "target": "FDA-CHUNK27-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-002",
      "target": "FDA-CHUNK27-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-003",
      "target": "FDA-CHUNK27-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-004",
      "target": "FDA-CHUNK27-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-005",
      "target": "FDA-CHUNK27-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-005",
      "target": "FDA-CHUNK28-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-006",
      "target": "FDA-CHUNK27-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK27-REQ-007",
      "target": "FDA-CHUNK28-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-001",
      "target": "FDA-CHUNK28-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-002",
      "target": "FDA-CHUNK28-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-003",
      "target": "FDA-CHUNK28-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-004",
      "target": "FDA-CHUNK28-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-005",
      "target": "FDA-CHUNK28-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK10-REQ-007",
      "target": "FDA-CHUNK11-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK12-REQ-007",
      "target": "FDA-CHUNK13-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK13-REQ-007",
      "target": "FDA-CHUNK14-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK14-REQ-008",
      "target": "FDA-CHUNK15-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-007",
      "target": "FDA-CHUNK18-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK18-REQ-008",
      "target": "FDA-CHUNK19-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK24-REQ-007",
      "target": "FDA-CHUNK25-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK26-REQ-007",
      "target": "FDA-CHUNK27-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK28-REQ-006",
      "target": "FDA-CHUNK29-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-001",
      "target": "FDA-CHUNK29-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-002",
      "target": "FDA-CHUNK29-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-003",
      "target": "FDA-CHUNK29-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-004",
      "target": "FDA-CHUNK29-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-005",
      "target": "FDA-CHUNK29-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK29-REQ-006",
      "target": "FDA-CHUNK30-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK30-REQ-001",
      "target": "FDA-CHUNK30-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK30-REQ-002",
      "target": "FDA-CHUNK30-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK30-REQ-003",
      "target": "FDA-CHUNK30-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK30-REQ-004",
      "target": "FDA-CHUNK30-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK30-REQ-005",
      "target": "FDA-CHUNK31-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-001",
      "target": "FDA-CHUNK31-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-002",
      "target": "FDA-CHUNK31-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-003",
      "target": "FDA-CHUNK31-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-004",
      "target": "FDA-CHUNK31-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-005",
      "target": "FDA-CHUNK32-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-005",
      "target": "FDA-CHUNK31-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK31-REQ-006",
      "target": "FDA-CHUNK32-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-001",
      "target": "FDA-CHUNK32-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-002",
      "target": "FDA-CHUNK32-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-003",
      "target": "FDA-CHUNK32-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-004",
      "target": "FDA-CHUNK32-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-005",
      "target": "FDA-CHUNK32-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK32-REQ-006",
      "target": "FDA-CHUNK33-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-001",
      "target": "FDA-CHUNK33-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-002",
      "target": "FDA-CHUNK33-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-003",
      "target": "FDA-CHUNK34-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.75,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-003",
      "target": "FDA-CHUNK33-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-004",
      "target": "FDA-CHUNK33-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-005",
      "target": "FDA-CHUNK33-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK33-REQ-006",
      "target": "FDA-CHUNK34-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-001",
      "target": "FDA-CHUNK34-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-002",
      "target": "FDA-CHUNK34-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-003",
      "target": "FDA-CHUNK34-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-004",
      "target": "FDA-CHUNK34-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-005",
      "target": "FDA-CHUNK34-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK34-REQ-006",
      "target": "FDA-CHUNK35-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-001",
      "target": "FDA-CHUNK35-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-002",
      "target": "FDA-CHUNK35-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-003",
      "target": "FDA-CHUNK35-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-004",
      "target": "FDA-CHUNK35-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-005",
      "target": "FDA-CHUNK35-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK35-REQ-006",
      "target": "FDA-CHUNK36-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-001",
      "target": "FDA-CHUNK36-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-002",
      "target": "FDA-CHUNK36-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-002",
      "target": "FDA-CHUNK36-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-003",
      "target": "FDA-CHUNK36-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-004",
      "target": "FDA-CHUNK36-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK36-REQ-005",
      "target": "FDA-CHUNK37-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-001",
      "target": "FDA-CHUNK37-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.88,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-001",
      "target": "FDA-CHUNK37-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-002",
      "target": "FDA-CHUNK37-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-003",
      "target": "FDA-CHUNK37-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-004",
      "target": "FDA-CHUNK37-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK37-REQ-005",
      "target": "FDA-CHUNK38-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-001",
      "target": "FDA-CHUNK38-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-002",
      "target": "FDA-CHUNK38-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-003",
      "target": "FDA-CHUNK38-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-004",
      "target": "FDA-CHUNK38-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-005",
      "target": "FDA-CHUNK38-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-006",
      "target": "FDA-CHUNK38-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK38-REQ-007",
      "target": "FDA-CHUNK39-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-001",
      "target": "FDA-CHUNK39-REQ-003",
      "relation": "RELATED_TO",
      "confidence": 0.84,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-001",
      "target": "FDA-CHUNK39-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-002",
      "target": "FDA-CHUNK39-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-003",
      "target": "FDA-CHUNK39-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-004",
      "target": "FDA-CHUNK39-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-005",
      "target": "FDA-CHUNK39-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-005",
      "target": "FDA-CHUNK39-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-006",
      "target": "FDA-CHUNK39-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK39-REQ-007",
      "target": "FDA-CHUNK40-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-001",
      "target": "FDA-CHUNK40-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-001",
      "target": "FDA-CHUNK40-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-002",
      "target": "FDA-CHUNK40-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-003",
      "target": "FDA-CHUNK40-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-004",
      "target": "FDA-CHUNK40-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-005",
      "target": "FDA-CHUNK40-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-006",
      "target": "FDA-CHUNK40-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK40-REQ-007",
      "target": "FDA-CHUNK41-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK41-REQ-001",
      "target": "FDA-CHUNK41-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK41-REQ-002",
      "target": "FDA-CHUNK41-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK41-REQ-003",
      "target": "FDA-CHUNK41-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK41-REQ-004",
      "target": "FDA-CHUNK41-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK41-REQ-005",
      "target": "FDA-CHUNK42-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK42-REQ-001",
      "target": "FDA-CHUNK42-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK42-REQ-002",
      "target": "FDA-CHUNK42-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK42-REQ-003",
      "target": "FDA-CHUNK42-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK42-REQ-004",
      "target": "FDA-CHUNK42-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK42-REQ-005",
      "target": "FDA-CHUNK43-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-001",
      "target": "FDA-CHUNK43-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-002",
      "target": "FDA-CHUNK43-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-003",
      "target": "FDA-CHUNK43-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-004",
      "target": "FDA-CHUNK43-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-005",
      "target": "FDA-CHUNK43-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK43-REQ-006",
      "target": "FDA-CHUNK44-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK44-REQ-001",
      "target": "FDA-CHUNK44-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK44-REQ-002",
      "target": "FDA-CHUNK44-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK44-REQ-003",
      "target": "FDA-CHUNK44-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK44-REQ-004",
      "target": "FDA-CHUNK44-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK44-REQ-005",
      "target": "FDA-CHUNK45-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-001",
      "target": "FDA-CHUNK45-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-002",
      "target": "FDA-CHUNK45-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-003",
      "target": "FDA-CHUNK45-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-004",
      "target": "FDA-CHUNK45-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-005",
      "target": "FDA-CHUNK45-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK45-REQ-006",
      "target": "FDA-CHUNK46-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-001",
      "target": "FDA-CHUNK47-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-001",
      "target": "FDA-CHUNK46-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-002",
      "target": "FDA-CHUNK46-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-003",
      "target": "FDA-CHUNK46-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-004",
      "target": "FDA-CHUNK46-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK46-REQ-005",
      "target": "FDA-CHUNK47-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-001",
      "target": "FDA-CHUNK47-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-002",
      "target": "FDA-CHUNK47-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-003",
      "target": "FDA-CHUNK47-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-004",
      "target": "FDA-CHUNK48-REQ-002",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-004",
      "target": "FDA-CHUNK47-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-005",
      "target": "FDA-CHUNK47-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK47-REQ-006",
      "target": "FDA-CHUNK48-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-001",
      "target": "FDA-CHUNK48-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-002",
      "target": "FDA-CHUNK48-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-003",
      "target": "FDA-CHUNK48-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-004",
      "target": "FDA-CHUNK48-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-005",
      "target": "FDA-CHUNK48-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK48-REQ-006",
      "target": "FDA-CHUNK49-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-001",
      "target": "FDA-CHUNK46-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-001",
      "target": "FDA-CHUNK49-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-002",
      "target": "FDA-CHUNK49-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-003",
      "target": "FDA-CHUNK49-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-004",
      "target": "FDA-CHUNK49-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-005",
      "target": "FDA-CHUNK49-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK49-REQ-006",
      "target": "FDA-CHUNK50-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-001",
      "target": "FDA-CHUNK52-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-001",
      "target": "FDA-CHUNK50-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-002",
      "target": "FDA-CHUNK50-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-003",
      "target": "FDA-CHUNK50-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-004",
      "target": "FDA-CHUNK50-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-005",
      "target": "FDA-CHUNK50-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK50-REQ-006",
      "target": "FDA-CHUNK51-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-001",
      "target": "FDA-CHUNK51-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.82,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-001",
      "target": "FDA-CHUNK51-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-002",
      "target": "FDA-CHUNK51-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-003",
      "target": "FDA-CHUNK51-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-004",
      "target": "FDA-CHUNK51-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK51-REQ-005",
      "target": "FDA-CHUNK52-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-001",
      "target": "FDA-CHUNK52-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-002",
      "target": "FDA-CHUNK52-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-003",
      "target": "FDA-CHUNK52-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-004",
      "target": "FDA-CHUNK52-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-005",
      "target": "FDA-CHUNK52-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-006",
      "target": "FDA-CHUNK52-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK52-REQ-007",
      "target": "FDA-CHUNK53-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK53-REQ-001",
      "target": "FDA-CHUNK53-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK53-REQ-002",
      "target": "FDA-CHUNK53-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK53-REQ-003",
      "target": "FDA-CHUNK53-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK53-REQ-004",
      "target": "FDA-CHUNK53-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK53-REQ-005",
      "target": "FDA-CHUNK54-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-001",
      "target": "FDA-CHUNK54-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-002",
      "target": "FDA-CHUNK54-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-003",
      "target": "FDA-CHUNK54-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-004",
      "target": "FDA-CHUNK54-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-005",
      "target": "FDA-CHUNK54-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK54-REQ-006",
      "target": "FDA-CHUNK55-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-001",
      "target": "FDA-CHUNK56-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-001",
      "target": "FDA-CHUNK55-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-002",
      "target": "FDA-CHUNK55-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-003",
      "target": "FDA-CHUNK55-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-004",
      "target": "FDA-CHUNK55-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-005",
      "target": "FDA-CHUNK55-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-006",
      "target": "FDA-CHUNK56-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK55-REQ-006",
      "target": "FDA-CHUNK56-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK56-REQ-001",
      "target": "FDA-CHUNK56-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK56-REQ-002",
      "target": "FDA-CHUNK56-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK56-REQ-003",
      "target": "FDA-CHUNK56-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK56-REQ-004",
      "target": "FDA-CHUNK56-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK56-REQ-005",
      "target": "FDA-CHUNK57-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK57-REQ-001",
      "target": "FDA-CHUNK57-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK57-REQ-002",
      "target": "FDA-CHUNK57-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK57-REQ-003",
      "target": "FDA-CHUNK57-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK57-REQ-004",
      "target": "FDA-CHUNK57-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK57-REQ-005",
      "target": "FDA-CHUNK58-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-001",
      "target": "FDA-CHUNK58-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-002",
      "target": "FDA-CHUNK58-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-003",
      "target": "FDA-CHUNK58-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-004",
      "target": "FDA-CHUNK58-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-004",
      "target": "FDA-CHUNK59-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-005",
      "target": "FDA-CHUNK58-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK58-REQ-006",
      "target": "FDA-CHUNK59-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-001",
      "target": "FDA-CHUNK59-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-002",
      "target": "FDA-CHUNK59-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-003",
      "target": "FDA-CHUNK59-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-004",
      "target": "FDA-CHUNK59-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-005",
      "target": "FDA-CHUNK59-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-006",
      "target": "FDA-CHUNK59-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK59-REQ-007",
      "target": "FDA-CHUNK60-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-001",
      "target": "FDA-CHUNK60-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-002",
      "target": "FDA-CHUNK60-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-003",
      "target": "FDA-CHUNK60-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-004",
      "target": "FDA-CHUNK60-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-005",
      "target": "FDA-CHUNK60-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK60-REQ-006",
      "target": "FDA-CHUNK61-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-001",
      "target": "FDA-CHUNK61-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-002",
      "target": "FDA-CHUNK61-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-003",
      "target": "FDA-CHUNK61-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-004",
      "target": "FDA-CHUNK61-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-005",
      "target": "FDA-CHUNK61-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK61-REQ-006",
      "target": "FDA-CHUNK62-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-001",
      "target": "FDA-CHUNK62-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-002",
      "target": "FDA-CHUNK62-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-003",
      "target": "FDA-CHUNK62-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-004",
      "target": "FDA-CHUNK62-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-005",
      "target": "FDA-CHUNK62-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-006",
      "target": "FDA-CHUNK62-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-007",
      "target": "FDA-CHUNK62-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK62-REQ-008",
      "target": "FDA-CHUNK63-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-001",
      "target": "FDA-CHUNK63-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-002",
      "target": "FDA-CHUNK63-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-003",
      "target": "FDA-CHUNK63-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-004",
      "target": "FDA-CHUNK63-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-005",
      "target": "FDA-CHUNK63-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK63-REQ-006",
      "target": "FDA-CHUNK64-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-001",
      "target": "FDA-CHUNK64-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-002",
      "target": "FDA-CHUNK64-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-003",
      "target": "FDA-CHUNK64-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-004",
      "target": "FDA-CHUNK64-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-005",
      "target": "FDA-CHUNK64-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK64-REQ-006",
      "target": "FDA-CHUNK65-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-001",
      "target": "FDA-CHUNK65-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-002",
      "target": "FDA-CHUNK65-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-003",
      "target": "FDA-CHUNK65-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-004",
      "target": "FDA-CHUNK65-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-005",
      "target": "FDA-CHUNK65-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK65-REQ-006",
      "target": "FDA-CHUNK66-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-001",
      "target": "FDA-CHUNK65-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-001",
      "target": "FDA-CHUNK66-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-002",
      "target": "FDA-CHUNK66-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-003",
      "target": "FDA-CHUNK66-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-004",
      "target": "FDA-CHUNK66-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-005",
      "target": "FDA-CHUNK66-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-006",
      "target": "FDA-CHUNK65-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK66-REQ-006",
      "target": "FDA-CHUNK67-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-001",
      "target": "FDA-CHUNK67-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-002",
      "target": "FDA-CHUNK67-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-003",
      "target": "FDA-CHUNK67-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-004",
      "target": "FDA-CHUNK67-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-005",
      "target": "FDA-CHUNK67-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK67-REQ-006",
      "target": "FDA-CHUNK68-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK68-REQ-001",
      "target": "FDA-CHUNK68-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK68-REQ-002",
      "target": "FDA-CHUNK68-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK68-REQ-003",
      "target": "FDA-CHUNK68-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK68-REQ-004",
      "target": "FDA-CHUNK68-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK68-REQ-005",
      "target": "FDA-CHUNK69-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-001",
      "target": "FDA-CHUNK69-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.83,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-001",
      "target": "FDA-CHUNK69-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-002",
      "target": "FDA-CHUNK69-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-003",
      "target": "FDA-CHUNK69-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-004",
      "target": "FDA-CHUNK69-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-005",
      "target": "FDA-CHUNK69-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-006",
      "target": "FDA-CHUNK69-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK69-REQ-007",
      "target": "FDA-CHUNK70-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-001",
      "target": "FDA-CHUNK70-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-002",
      "target": "FDA-CHUNK70-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-003",
      "target": "FDA-CHUNK70-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-004",
      "target": "FDA-CHUNK70-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-005",
      "target": "FDA-CHUNK70-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK70-REQ-006",
      "target": "FDA-CHUNK71-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-001",
      "target": "FDA-CHUNK71-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-002",
      "target": "FDA-CHUNK71-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-003",
      "target": "FDA-CHUNK71-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-004",
      "target": "FDA-CHUNK71-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-005",
      "target": "FDA-CHUNK71-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK71-REQ-006",
      "target": "FDA-CHUNK72-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-001",
      "target": "FDA-CHUNK72-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-002",
      "target": "FDA-CHUNK72-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-003",
      "target": "FDA-CHUNK72-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-004",
      "target": "FDA-CHUNK72-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-005",
      "target": "FDA-CHUNK72-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK72-REQ-006",
      "target": "FDA-CHUNK73-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-001",
      "target": "FDA-CHUNK73-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-002",
      "target": "FDA-CHUNK73-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-003",
      "target": "FDA-CHUNK73-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-004",
      "target": "FDA-CHUNK73-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-005",
      "target": "FDA-CHUNK73-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK73-REQ-006",
      "target": "FDA-CHUNK74-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-001",
      "target": "FDA-CHUNK74-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-002",
      "target": "FDA-CHUNK74-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-003",
      "target": "FDA-CHUNK74-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-004",
      "target": "FDA-CHUNK74-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-005",
      "target": "FDA-CHUNK74-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK74-REQ-006",
      "target": "FDA-CHUNK75-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-001",
      "target": "FDA-CHUNK75-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-002",
      "target": "FDA-CHUNK75-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-003",
      "target": "FDA-CHUNK75-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-004",
      "target": "FDA-CHUNK75-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-005",
      "target": "FDA-CHUNK75-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK75-REQ-006",
      "target": "FDA-CHUNK76-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-001",
      "target": "FDA-CHUNK76-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-002",
      "target": "FDA-CHUNK76-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-003",
      "target": "FDA-CHUNK76-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-004",
      "target": "FDA-CHUNK76-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-005",
      "target": "FDA-CHUNK76-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK76-REQ-006",
      "target": "FDA-CHUNK77-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK77-REQ-001",
      "target": "FDA-CHUNK77-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK77-REQ-002",
      "target": "FDA-CHUNK77-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK77-REQ-003",
      "target": "FDA-CHUNK77-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK77-REQ-004",
      "target": "FDA-CHUNK77-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK77-REQ-005",
      "target": "FDA-CHUNK78-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-001",
      "target": "FDA-CHUNK78-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-002",
      "target": "FDA-CHUNK78-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-003",
      "target": "FDA-CHUNK78-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-004",
      "target": "FDA-CHUNK78-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-005",
      "target": "FDA-CHUNK78-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK78-REQ-006",
      "target": "FDA-CHUNK79-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK79-REQ-001",
      "target": "FDA-CHUNK79-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK79-REQ-002",
      "target": "FDA-CHUNK79-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK79-REQ-003",
      "target": "FDA-CHUNK79-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK79-REQ-004",
      "target": "FDA-CHUNK79-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK79-REQ-005",
      "target": "FDA-CHUNK80-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK80-REQ-001",
      "target": "FDA-CHUNK80-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK80-REQ-002",
      "target": "FDA-CHUNK80-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK80-REQ-003",
      "target": "FDA-CHUNK80-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK80-REQ-004",
      "target": "FDA-CHUNK80-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK80-REQ-005",
      "target": "FDA-CHUNK81-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-001",
      "target": "FDA-CHUNK81-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-002",
      "target": "FDA-CHUNK81-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-003",
      "target": "FDA-CHUNK81-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-004",
      "target": "FDA-CHUNK81-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-005",
      "target": "FDA-CHUNK81-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK81-REQ-006",
      "target": "FDA-CHUNK82-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-001",
      "target": "FDA-CHUNK82-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-002",
      "target": "FDA-CHUNK82-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-003",
      "target": "FDA-CHUNK82-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-004",
      "target": "FDA-CHUNK82-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-005",
      "target": "FDA-CHUNK82-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK82-REQ-006",
      "target": "FDA-CHUNK83-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-001",
      "target": "FDA-CHUNK83-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-002",
      "target": "FDA-CHUNK83-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-003",
      "target": "FDA-CHUNK83-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-004",
      "target": "FDA-CHUNK83-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-005",
      "target": "FDA-CHUNK83-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK83-REQ-006",
      "target": "FDA-CHUNK84-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-001",
      "target": "FDA-CHUNK84-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-002",
      "target": "FDA-CHUNK84-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-003",
      "target": "FDA-CHUNK84-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-004",
      "target": "FDA-CHUNK84-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-005",
      "target": "FDA-CHUNK84-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-005",
      "target": "FDA-CHUNK84-REQ-007",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-006",
      "target": "FDA-CHUNK84-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK84-REQ-007",
      "target": "FDA-CHUNK85-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-001",
      "target": "FDA-CHUNK85-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-002",
      "target": "FDA-CHUNK85-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-003",
      "target": "FDA-CHUNK85-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-004",
      "target": "FDA-CHUNK85-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-005",
      "target": "FDA-CHUNK85-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK85-REQ-006",
      "target": "FDA-CHUNK86-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-001",
      "target": "FDA-CHUNK86-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-002",
      "target": "FDA-CHUNK86-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-003",
      "target": "FDA-CHUNK86-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-004",
      "target": "FDA-CHUNK86-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-005",
      "target": "FDA-CHUNK86-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK86-REQ-006",
      "target": "FDA-CHUNK87-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-001",
      "target": "FDA-CHUNK87-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-001",
      "target": "FDA-CHUNK87-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-002",
      "target": "FDA-CHUNK87-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-003",
      "target": "FDA-CHUNK87-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-004",
      "target": "FDA-CHUNK87-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-005",
      "target": "FDA-CHUNK87-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK87-REQ-006",
      "target": "FDA-CHUNK88-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-001",
      "target": "FDA-CHUNK88-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-002",
      "target": "FDA-CHUNK88-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-003",
      "target": "FDA-CHUNK88-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-004",
      "target": "FDA-CHUNK88-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-005",
      "target": "FDA-CHUNK88-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK88-REQ-006",
      "target": "FDA-CHUNK89-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK89-REQ-001",
      "target": "FDA-CHUNK89-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK89-REQ-002",
      "target": "FDA-CHUNK89-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK89-REQ-003",
      "target": "FDA-CHUNK89-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK89-REQ-004",
      "target": "FDA-CHUNK89-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK89-REQ-005",
      "target": "FDA-CHUNK90-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK90-REQ-001",
      "target": "FDA-CHUNK90-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK90-REQ-002",
      "target": "FDA-CHUNK90-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK90-REQ-003",
      "target": "FDA-CHUNK90-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK90-REQ-004",
      "target": "FDA-CHUNK90-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK90-REQ-005",
      "target": "FDA-CHUNK91-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-001",
      "target": "FDA-CHUNK91-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-002",
      "target": "FDA-CHUNK91-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-003",
      "target": "FDA-CHUNK91-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-004",
      "target": "FDA-CHUNK91-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-005",
      "target": "FDA-CHUNK91-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK91-REQ-006",
      "target": "FDA-CHUNK92-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-001",
      "target": "FDA-CHUNK92-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-002",
      "target": "FDA-CHUNK92-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-003",
      "target": "FDA-CHUNK94-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.95,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-003",
      "target": "FDA-CHUNK92-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-004",
      "target": "FDA-CHUNK92-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-005",
      "target": "FDA-CHUNK92-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK92-REQ-006",
      "target": "FDA-CHUNK93-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-001",
      "target": "FDA-CHUNK93-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-001",
      "target": "FDA-CHUNK93-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-002",
      "target": "FDA-CHUNK93-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-003",
      "target": "FDA-CHUNK93-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-004",
      "target": "FDA-CHUNK94-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.85,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-004",
      "target": "FDA-CHUNK93-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-005",
      "target": "FDA-CHUNK93-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-006",
      "target": "FDA-CHUNK93-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK93-REQ-007",
      "target": "FDA-CHUNK94-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-001",
      "target": "FDA-CHUNK94-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-002",
      "target": "FDA-CHUNK94-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-003",
      "target": "FDA-CHUNK94-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-004",
      "target": "FDA-CHUNK94-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-005",
      "target": "FDA-CHUNK94-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-006",
      "target": "FDA-CHUNK94-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-007",
      "target": "FDA-CHUNK94-REQ-008",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK94-REQ-008",
      "target": "FDA-CHUNK95-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-001",
      "target": "FDA-CHUNK95-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-002",
      "target": "FDA-CHUNK95-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-003",
      "target": "FDA-CHUNK95-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-004",
      "target": "FDA-CHUNK95-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-005",
      "target": "FDA-CHUNK95-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK95-REQ-006",
      "target": "FDA-CHUNK96-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK96-REQ-001",
      "target": "FDA-CHUNK96-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK96-REQ-002",
      "target": "FDA-CHUNK96-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK96-REQ-003",
      "target": "FDA-CHUNK96-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK96-REQ-004",
      "target": "FDA-CHUNK96-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK96-REQ-005",
      "target": "FDA-CHUNK97-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK97-REQ-001",
      "target": "FDA-CHUNK97-REQ-004",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK97-REQ-001",
      "target": "FDA-CHUNK97-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK97-REQ-002",
      "target": "FDA-CHUNK97-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK97-REQ-003",
      "target": "FDA-CHUNK97-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK97-REQ-004",
      "target": "FDA-CHUNK98-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-001",
      "target": "FDA-CHUNK98-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-002",
      "target": "FDA-CHUNK98-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-003",
      "target": "FDA-CHUNK98-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-004",
      "target": "FDA-CHUNK98-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-005",
      "target": "FDA-CHUNK98-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-006",
      "target": "FDA-CHUNK98-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK98-REQ-007",
      "target": "FDA-CHUNK99-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK99-REQ-001",
      "target": "FDA-CHUNK99-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK99-REQ-002",
      "target": "FDA-CHUNK99-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK99-REQ-003",
      "target": "FDA-CHUNK99-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK99-REQ-004",
      "target": "FDA-CHUNK99-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK99-REQ-005",
      "target": "FDA-CHUNK100-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-001",
      "target": "FDA-CHUNK100-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-002",
      "target": "FDA-CHUNK100-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-003",
      "target": "FDA-CHUNK100-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-004",
      "target": "FDA-CHUNK100-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-005",
      "target": "FDA-CHUNK100-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK100-REQ-006",
      "target": "FDA-CHUNK101-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK101-REQ-001",
      "target": "FDA-CHUNK101-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK101-REQ-002",
      "target": "FDA-CHUNK101-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK101-REQ-003",
      "target": "FDA-CHUNK101-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK101-REQ-004",
      "target": "FDA-CHUNK101-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK101-REQ-005",
      "target": "FDA-CHUNK102-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-001",
      "target": "FDA-CHUNK102-REQ-005",
      "relation": "RELATED_TO",
      "confidence": 0.8,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-001",
      "target": "FDA-CHUNK102-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-002",
      "target": "FDA-CHUNK102-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-003",
      "target": "FDA-CHUNK102-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-004",
      "target": "FDA-CHUNK102-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK102-REQ-005",
      "target": "FDA-CHUNK103-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-001",
      "target": "FDA-CHUNK103-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-002",
      "target": "FDA-CHUNK103-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-003",
      "target": "FDA-CHUNK103-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-004",
      "target": "FDA-CHUNK103-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-005",
      "target": "FDA-CHUNK103-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK103-REQ-006",
      "target": "FDA-CHUNK104-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-001",
      "target": "FDA-CHUNK104-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-002",
      "target": "FDA-CHUNK104-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-003",
      "target": "FDA-CHUNK104-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-004",
      "target": "FDA-CHUNK104-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-005",
      "target": "FDA-CHUNK104-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-006",
      "target": "FDA-CHUNK104-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK104-REQ-007",
      "target": "FDA-CHUNK105-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-001",
      "target": "FDA-CHUNK105-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-002",
      "target": "FDA-CHUNK105-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-003",
      "target": "FDA-CHUNK105-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-004",
      "target": "FDA-CHUNK105-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-005",
      "target": "FDA-CHUNK105-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-006",
      "target": "FDA-CHUNK105-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK105-REQ-007",
      "target": "FDA-CHUNK106-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-001",
      "target": "FDA-CHUNK106-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-002",
      "target": "FDA-CHUNK106-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-003",
      "target": "FDA-CHUNK106-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-004",
      "target": "FDA-CHUNK106-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-005",
      "target": "FDA-CHUNK106-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK106-REQ-006",
      "target": "FDA-CHUNK107-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-001",
      "target": "FDA-CHUNK107-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-002",
      "target": "FDA-CHUNK107-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-003",
      "target": "FDA-CHUNK107-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-004",
      "target": "FDA-CHUNK107-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-005",
      "target": "FDA-CHUNK107-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK107-REQ-006",
      "target": "FDA-CHUNK108-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK108-REQ-001",
      "target": "FDA-CHUNK108-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK108-REQ-002",
      "target": "FDA-CHUNK108-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK108-REQ-003",
      "target": "FDA-CHUNK108-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK108-REQ-004",
      "target": "FDA-CHUNK108-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK108-REQ-005",
      "target": "FDA-CHUNK109-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-001",
      "target": "FDA-CHUNK109-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-002",
      "target": "FDA-CHUNK109-REQ-001",
      "relation": "RELATED_TO",
      "confidence": 0.75,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-002",
      "target": "FDA-CHUNK109-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-003",
      "target": "FDA-CHUNK109-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-004",
      "target": "FDA-CHUNK109-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-004",
      "target": "FDA-CHUNK109-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.9,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-005",
      "target": "FDA-CHUNK109-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK109-REQ-006",
      "target": "FDA-CHUNK110-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-001",
      "target": "FDA-CHUNK110-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-002",
      "target": "FDA-CHUNK110-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-003",
      "target": "FDA-CHUNK110-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-004",
      "target": "FDA-CHUNK110-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-005",
      "target": "FDA-CHUNK110-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK110-REQ-006",
      "target": "FDA-CHUNK111-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-001",
      "target": "FDA-CHUNK112-REQ-006",
      "relation": "RELATED_TO",
      "confidence": 0.86,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-001",
      "target": "FDA-CHUNK111-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-002",
      "target": "FDA-CHUNK111-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-003",
      "target": "FDA-CHUNK111-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-004",
      "target": "FDA-CHUNK111-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-005",
      "target": "FDA-CHUNK111-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-006",
      "target": "FDA-CHUNK111-REQ-007",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK111-REQ-007",
      "target": "FDA-CHUNK112-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-001",
      "target": "FDA-CHUNK112-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-002",
      "target": "FDA-CHUNK112-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-003",
      "target": "FDA-CHUNK112-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-004",
      "target": "FDA-CHUNK112-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-005",
      "target": "FDA-CHUNK112-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK112-REQ-006",
      "target": "FDA-CHUNK113-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-001",
      "target": "FDA-CHUNK113-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-002",
      "target": "FDA-CHUNK113-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-003",
      "target": "FDA-CHUNK113-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-004",
      "target": "FDA-CHUNK113-REQ-005",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-005",
      "target": "FDA-CHUNK113-REQ-006",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK113-REQ-006",
      "target": "FDA-CHUNK114-REQ-001",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK114-REQ-001",
      "target": "FDA-CHUNK114-REQ-002",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK114-REQ-002",
      "target": "FDA-CHUNK114-REQ-003",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    },
    {
      "source": "FDA-CHUNK114-REQ-003",
      "target": "FDA-CHUNK114-REQ-004",
      "relation": "NEARBY",
      "confidence": 1.0,
      "source_type": ""
    }
  ],
  "stats": {
    "num_nodes": 702,
    "num_edges": 801,
    "node_types": {
      "clause": 702
    },
    "edge_types": {
      "NEARBY": 730,
      "RELATED_TO": 71
    }
  }
}